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Every great wizard in history has started out as nothing more than what we are 
now, students. If they can do it, why not us? 
― J.K. Rowling 
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Abstract 
Huntington’s disease (HD) is a rare, neurodegenerative, progressive, 
autosomal dominant disorder caused by an expanded cytosine-adenine-guanine 
(CAG) repeat in the HTT gene located at the 4p16.3 locus. Repeat size is variable and 
known to influence several aspects of the disease such as penetrance and age-of-
onset. The repeat is unstable across generations and in patient tissues. Large size 
changes toward expansions in intergenerational transmissions contribute to the 
anticipation observed in the disorder, sometimes leading to extremely early disease 
onset. Somatic changes in repeat size, also seem to contribute toward the modulation 
of age-of-onset. Understanding the factors that contribute to CAG repeat instability is 
of the utmost importance for the discovery and application of possible therapies, aimed 
either at preventing CAG repeat size expansions or inducing CAG contractions. There 
is currently no cure for the disease, so, targeting its gene is a good approach that hits 
the cause of the disease. Therefore, all the studies presented here have different 
specific goals, but share the overall objective of finding and understanding the factors 
that influence CAG repeat instability, using HD patient cells and mouse models for the 
disorder. 
Instability was characterized in lymphoblastoid cell lines (LCLs), from 
individuals belonging to a nuclear family in which the father presented a high frequency 
of intergenerationally unstable transmissions in order to examine the behavior of the 
CAG repeat overtime in culture. These analyses did not highlight any particularly high 
instability in the LCLs of the father, suggesting that the high levels of instability that 
appear to be present in his germline may not be recapitulated in his somatic cells. 
These analyses also provided the opportunity to assess the feasibility of using LCLs 
as a cell-based model for conducting screens of instability altering factors. The results 
suggested that LCLs likely do not provide good models for this purpose due either to 
very modest repeat size changes in cells with  lower repeat lengths, or highly 
heterogeneous and variable repeat size populations in cells with high repeat lengths, 
severely hindering interpretation.  
Despite the apparent absence of an obvious connection between high 
intergenerational and somatic instability in the father of the nuclear family above, 
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through the evaluation of instability in LCLs and sperm samples across multiple 
individuals with expanded repeats, it is shown that germline and LCL instability, 
particularly expansions, are correlated. This indicates that contributors to somatic and 
germline instability may be shared. 
Possible correlations between instability measures and the expression levels 
of a group of genes involved in DNA replication and repair processes in a different set 
of HD patient and control LCLs, were studied as a hypothesis generating tool. This 
resulted in the identification of several significant and/or interesting results, indicating 
that genes such as NTHL1, POLD1, TP73, FAN1 and LIG1 might have a role in 
somatic instability. 
Intergenerational instability was studied using the largest breeding datasets of 
HD knock-in mouse models available to date: one contained data from several lines 
over a wide range of repeat sizes (HttQ20, HttQ50, HttQ80, HttQ92, HttQ111, HttQ140, and 
HttQ175) in the B6J background; the other contained data from a more limited set of 
alleles across six mouse strains (B6J, CD1, FVB, DBA, 129 and B6N). Several 
interesting conclusions came out of this study. We saw that the presence of a knock-
in allele does not skew the proportion of heterozygous versus wild-type mice 
independently of repeat size. We observed that parental sex influences the frequency 
of repeat changes, but sex-of-offspring does not seem to have any effect on instability. 
CAG repeat length influenced the frequency and magnitude of expansions but only 
the magnitude of contractions. A minor role of paternal age on expansion magnitude 
was also found. Genetic background (trans) effects were identified as modifiers of 
frequency and magnitude of changes when comparing the different strains, and Lig1 
and Spata31 may be involved in these differences. Consequences of cis-effectors  and 
were also found, specifically through the potential expansion protection effects when 
comparing lines with and without a neomycin resistance cassette (neo) sequence 
upstream of the CAG repeat. 
This same neo sequence also appeared to have a mild but significant effect in 
altering instability and diminish the somatic expansions, specifically in the liver of 
HttQ175 mice. 
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Overall, this work yielded multiple possibilities to be explored, and a better 
understanding of factors that modulate CAG repeat size, adding to the state of the art 
regarding instability of HD’s CAG repeat, bringing us closer to the possibility of 
targeting the repeat therapeutically and contributing to one day help patients and 
individuals at-risk for the disease.  
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Resumo 
A doença de Huntington (HD), é uma doença rara, neurdegenerativa, 
progressiva, autossómica dominante causada por uma repetição de citosina-adenina-
guanina (CAG) no gene HTT situado no locus 4p16.3. O tamanho desta repetição é 
variável e sabe-se que afeta vários aspetos da doença tal como a sua penetrância e 
a idade de início dos sintomas. A repetição é instável de geração para geração e em 
entre diferentes tecidos. Grandes expansões em transmissões intergeracionais 
contribuem para a anticipação observada na doença, conduzindo por vezes a uma 
idade de inicio extremamente precoce. Alterações somáticas no tamanho da repetição 
também contribuem para a modulação da idade de inicio. Perceber que fatores 
contribuem para a instabilidade da repetição é da maior importância para a 
descoberta e aplicação de terapias com o objetivo de prevenir expansões ou induzir 
contrações da sequência repetitiva. Atualmente não existe uma cura para a HD, 
portanto, procurar modular diretamente a causa genética da doença será uma 
abordagem apropriada. Todos os projetos aqui apresentados partilham um objetivo 
global, o de encontrar e compreender fatores que influenciam a instabilidade da 
repetição, nomeadamente com a utilização de células de doentes e modelos de 
murganho de HD. 
A instabilidade da repetição foi caracterizada em células linfoblastóides (LCLs) 
de indivíduos de uma família com HD em que o pai afetado apresenta uma alta 
frequência de transmissões instáveis intergeracionalmente, para perceber de que 
forma se comporta o tamanho da repetição nestas células ao longo do tempo em 
cultura. Este estudo não demonstrou uma particular instabilidade nas células 
somáticas do pai afectado, indicando que a instabilidade da sua linha germinativa não 
parece estar presente nas suas células somáticas. Neste projeto também se avaliou 
a potencial viabilidade de utilizar as LCLs como modelo para a procura de factores 
que modificam a instabilidade. Os resultados obtidos indicam-nos que este não será 
um modelo apropriado, uma vez que as linhas com repetições mais curtas 
apresentam alterações muito modestas no tamanho do alelo principal, enquanto que 
LCLs com repetições muito longas apresentam populações heterogéneas e de 
comportamento complexo, impedindo qualquer possível interpretação. 
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Apesar de não se ter observado uma correlação entre a instabilidade somática 
e instabilidade intergeracional no indivíduo acima referido, quando é avaliada a 
instabilidade em LCLs e amostras de esperma de um conjunto de doentes, 
demonstra-se que efectivamente existirá alguma relação entre a instabilidade 
somática e da linha germinativa, particularmente no que toca a expansões. Isto indica 
que ambas partilharão alguns elementos que contribuem para a instabilidade da 
repetição. 
Possíveis correlações entre instabilidade e a expressão de genes envolvidos 
em processos de replicação e reparação de DNA foram avaliadas, num conjunto de 
indivíduos, com o objetivo de gerar novas hipóteses relativamente a modificadores de 
instabilidade da repetição. Este estudo resultou na identificação de vários genes, 
nomeadamente NTHL1, POLD1, TP73, FAN1 e LIG1, como potenciais moduladores 
da instabilidade somática. 
A instabilidade intergeracional também foi estudada utilizando os maiores 
conjuntos de dados disponíveis até à data relativamente à manutenção de modelos 
de murganho de HD. Um destes conjuntos de dados incluia várias linhas (HttQ20, 
HttQ50, HttQ80, HttQ92, HttQ111, HttQ140, HttQ175) contendo um vasto intervalo de tamanhos 
de repetição e o outro contendo um intervalo de repetições mais curto, mas 
pertencendo a estirpes geneticamente distintas (129, CD1, FVB, DBA, 129 e B6N). 
Várias conclusões interessantes foram retiradas deste estudo. Observamos que a 
presença de um alelo knock-in não influencia a proporção de ratinhos heterozigóticos 
e wild-type, independentemente do tamanho da repetição. Concluímos que o sexo do 
progenitor transmissor da repetição influência a instabilidade, mas o sexo da cria não. 
O tamanho da repetição transmitida afeta a frequência e magnitude de expansões, 
mas apenas a magnitude no caso das contrações. Também se observou que a idade 
paternal terá algum papel na magnitude das expansões. Efeitos relativos ao 
background genético (efeitos em trans) também foram identificados, através da 
avaliação de alterações na instabilidade nas diferentes estirpes dos modelos de HD, 
sendo que genes como o Lig1 e o Spata31, poderão estar envolvidos neste processo. 
Também efeitos em cis foram identificados, nomeadamente a presença de uma 
cassete de resistência á neomicina (neo) a montante da repetição. 
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A mesma sequência neo, parece também ter um efeito moderado, mas 
significativo na alteração da instabilidade e na diminuição do indice de expansão 
somática em modelos HttQ175. 
Este trabalho gera uma multitude de possibilidades a explorar, e conduz a uma 
melhor compreensão dos fatores que modificam a instabilidade da repetição de 
CAGs, contribuindo para o estado-da-arte relativamente à instabilidade da repetição 
na HD, aproximando a probabilidade de utilização da modulação da repetição como 
alvo terapêutico, podendo no futuro ajudar doentes e indivíduos em risco para a 
doença. 
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1. General Introduction  
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In his paper On Chorea[1] published in 1872, Dr. George Huntington 
characterized a choreic disorder that, as he put it, “is peculiar in itself and seems to 
obey certain fixed laws”, providing the first comprehensive description of the disorder 
– that he simply termed hereditary chorea – now known as Huntington’s disease (HD).  
While there are possible earlier descriptions of the disease, Huntington’s paper 
concisely described most of the features present in the typical presentation of HD: its 
hereditary nature; the presence of cognitive and/or psychiatric symptoms (“tendency 
to insanity and suicide”); and its manifestation in adult life[1]. It does not seem that 
Huntington came across the juvenile form of the disorder, which constitutes only a 
small relative amount of HD patients[2–4] and presents clinical features distinct from 
the adult-onset disease, notably lacking chorea[2].  
1.1. Epidemiology 
Prevalence of HD has been estimated for many decades across the globe 
showing high heterogeneity among populations, with differences up to several fold. 
Lower prevalence is estimated in African and Asian populations (≤1 per 100,000), 
while Western populations show higher prevalence, namely, 2-5 per 100,000 in 
Portugal and ~7.5 per 100,000 in North America[5,6]. 
1.2. Huntington’s disease clinical symptoms, disease progression and 
diagnosis 
Most of HD’s symptoms may be classified in three categories: progressive 
motor, cognitive and psychiatric features. 
1.2.1. Motor symptoms 
Numerous motor symptoms are observed in HD patients. As stated previously, 
chorea is a very prominent occurrence, specially early in the disease, and consists of 
short-lived, excessive involuntary movements present whenever the patients are in an 
awake state[2], other dyskinetic symptoms, for instance, intermittent and stereotyped 
movements (“tics”), such as head jerking, sniffing or blinking, are usually also 
present[2,3,7]. Later in the disease, the hyperkinesia tends to lessen, but dystonia 
(involuntary, uncontrolled muscle contractions and tone), akinesia (hindrance in 
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commencing movement), bradykinesia (slowness of movement) and rigidity appear 
more prevalently[2,3,7]. Juvenile-onset HD also frequently presents myoclonic 
seizures[2,4] along with dystonia, bradykinesia, and spasticity[4]. External phenomena 
and psychiatric aspects (e.g. infections, anxiety, stress) may lead to transitory 
worsening of these symptoms[2]. 
1.2.2. Cognitive symptoms  
High-level processing and executive functioning are altered in HD, causing 
slowing of thought processing, impairment of organizational skills, and planning, 
problems in initiating actions, concentration and multitasking[3,7]. Short-term memory 
and visuospatial and perceptual skills are also affected[7]. Some of these features 
occur early in the disease process and together, all of these deficits might severely 
hamper every-day life, independently of difficulties caused by the motor 
symptoms[2,3,7]. The juvenile form of the disorder also presents additional symptoms, 
namely in the form of early learning difficulties or disability[7]. 
1.2.3. Psychiatric symptoms 
Like cognitive features, psychiatric symptoms usually precede motor 
phenotypes and are an early occurrence in HD. Some of these symptoms might be 
hard to, at first, link with the disorder as they might be attributed to other underlying 
causes[2]. Depression and anxiety are the most common mental disturbances in HD. 
Suicidal ideation is also fairly prevalent, a fact that George Huntington also noticed in 
his early description of the disorder[1]. Apathy, irritability and aggression are also 
present. Some of these psychiatric features often are dealt with symptomatically, as 
overall treatment for HD is not available as of yet[3]. 
1.2.4. Additional HD symptoms 
The sleep-wake phases are disrupted causing sleep disturbance which might 
lead to somnolence during daytime[3]. Metabolic problems are also present, leading 
to a catabolic state which causes severe weight loss[2,3,7]. Skeletal muscle atrophy 
is also observed[2]. Other conditions are also present in advanced stages of the 
disorder, namely, muteness which usually hampers the patients’ ability to 
communicate[7], and dysphagia, which hinders the ability to provide proper nutrition 
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to patients, who need a high caloric intake due to the catabolic phenotype[2,3,7]. 
Cardiac failure is also common in HD affected individuals and is the leading cause of 
death in roughly one third of patients[8]. 
1.3. Pathology 
1.3.1. Neuropathology 
HD’s motor, cognitive and psychiatric symptoms have been related to its 
neuropathological changes[9], such as neurodegeneration and neuronal loss[9–12]. 
Brain structural irregularities precede HD clinical symptoms, and affect to some extent 
the whole organ[12], and might end in a ~20% loss of brain volume[11] and up to 20-
30% of total brain weight[9,10,12]. Nevertheless, particular areas of the brain are more 
altered then others. The basal ganglia is preferentially affected; more specifically, the 
striatum (caudate nucleus and putamen) shows a large loss of neuron numbers as 
well as astrogliosis, which worsen with disease progression resulting therefore in a 
gross atrophy and high reduction in total volume (~60%) of this structure in late stages 
of the disorder[11,12]. Within the striatum medium spiny neurons are the most 
vulnerable to degeneration[10,11,13,14]. HD neuropathology is categorized according 
to macro- and microscopic changes in the striatum, within – the Vonsattel Grading 
System[15] – one of five grades (0-4) according to the degree of severity, from lowest 
to highest, that usually correlate with the degree of clinical disability[10–12]. 
While the striatal atrophy is by far considered the main neuropathological 
hallmark of HD, detailed descriptions of degeneration in other brain regions (thalamus, 
cerebral cortex, hippocampus, among many others) have been thoroughly 
characterized and assessed[9–12]. 
1.3.2. Peripheral pathology 
Peripheral consequences are also present but might be less apparent in 
individuals with HD, among them: increased peripheral inflammation and dysfunction 
of blood-derived cells[8,16]; reduced number of germ cells are present in testis and 
male patients have reduced levels of testosterone[8]; decrease in insulin secretion and 
sensitivity[8]; and cardiac failure[8,16]. 
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While peripheral tissues do not seem to be the main ones affected in HD they 
are more easily accessible and substantially contribute to our understanding of the 
disorder[8]. 
1.4. Diagnosis 
Currently, formal diagnosis of the disorder is made clinically and requires the 
presence of extrapyramidal motor symptoms, with genetic testing providing a 
confirmation of the diagnosis[2,17]. 
1.5. Heredity and genetics 
The heritable nature of HD has been one of its most noticeable characteristics, 
with both the adult- and juvenile-onset forms being characterized in multi-generational 
families[1,18]. George Huntington even described its “pattern of inheritance”, referring 
to the observation that if people affected by the disorder have offspring, one or more 
will be affected, while individuals in these families that go through life unaffected by 
the disease are sure to have only non-affected descendants[1], matching the well 
described autosomal dominant inheritance pattern of HD[19]. 
The search and discovery of the gene underlying HD also resulted, in part, from 
thoroughly acquired data from HD families – one very large Venezuelan family from 
the region of Lake Maracaibo, where the disease originated from a single founder, and 
a reasonably large American family from Ohio. Initial efforts, using restriction fragment-
length polymorphism (RFLP) technology, mapped the gene to chromosome 4, an 
important breakthrough and the first fruitful linkage analyses using polymorphic 
markers in humans[20,21]. Furthermore, at the time, assuming HD’s genetic 
heterogeneity was non-existent, the marker shown to segregate with the disease could 
be tested in individuals at risk for the disorder[20], and was a first step of the utmost 
importance in the gene discovery[19].  
With molecular technology advancements, higher densities of genetic markers 
were achieved, eventually leading to a candidate region for the gene responsible for 
HD, located at the 4p16.3 locus, with 2.2Mb and a ~500kb region showing the highest 
overall linkage disequilibrium[19,22,23]. Exon trapping was used in this smaller region, 
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where a sequence initially dubbed “interesting transcript 15” (IT15) was found to have 
a polymorphic cytosine-adenine-guanine (CAG) repeat, which in the non-affected 
population mostly presented 11 to 24 repeats (with a very small percentage between 
25 and 34 CAGs), while all HD chromosomes possessed over 42 repeats[19]. The 
genetic cause of HD was hence found, consisting of this expanded trinucleotide repeat 
(TNR) in the – historically termed IT15, eventually renamed HD, and now called – HTT 
gene. 
The repeat is located in exon 1 of HTT and encodes a polyglutamine (polyQ) 
stretch in the N-terminal region of the huntingtin protein[13,18,19,24]. HTT is 
expressed ubiquitously, with highest expression in the brain[8,25–28], although 
expression levels in specific brain regions do not overlap with severity of 
neuropathological changes[29]. 
Huntingtin does not share an extensive homology with other proteins, and 
therefore at the time of the gene’s discovery its function was unknown[19]. Even 
though nowadays we know huntingtin is involved in a myriad of cellular processes and 
pathways (such as transcription, cell division, vesicular trafficking, and autophagy, 
among others)[24,28], there still is no clear idea of “wild-type” huntingtin’s cellular 
function[28].  
Many possible pathogenic pathways have been described and studied 
thoroughly are thought to be primarily a consequence of a toxic gain-of-function in the 
mutant huntingtin[24], although there might be a smaller contribution from loss-of-
function due to lower levels of non-expanded protein[28]. Furthermore, expanded 
polyQ leads to the formation of large intracellular inclusions and 
aggregates[10,12,24,28], and although these do not seem to correlate with 
cytotoxicity[30–32] it is unclear if oligomeric precursors, such as amyloid fibrils might 
play a pathogenic role associated with the toxic gain-of-function[24].  
Nonetheless, the overall upstream culprit of the disorder is the expanded CAG 
repeat which modulates many aspects of HD, such as disease penetrance and age-
at-onset. 
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1.6. CAG repeat length and disease penetrance 
Shortly after the discovery of the causal mutation, different groups started 
quantifying repeat sizes in large HD cohorts[33–38], in order to “fine tune” the intervals 
that would result in developing the disorder or not.  
Currently, HTT CAG repeat sizes are divided into four categories (Figure 1): 1) 
Normal alleles, which have TNRs with less than or equal to 26 repeats (the most 
frequent repeat sizes are between 17 and 19, but might go as low as 6 CAGs). These 
do not lead to disease, and are stable in over 99% of meiosis; 2) High normal alleles 
– commonly referred to as intermediate alleles – which possess between 27 and 35 
repeats, are carried by ~2% of the population, and there is an overall consensus that 
they do not lead to disease. In this range, there are no reports of unstable maternal 
meiosis, although in paternal transmissions these alleles might expand to disease-
causing alleles; 3) Reduced penetrance alleles, where 36 to 39 CAGs are present, 
have been associated with HD’s clinical and neuropathological symptoms, however, 
non-affected elderly individuals with the aforementioned repeat sizes have been 
reported, showing that disease penetrance is not complete in this range. These alleles 
are unstable meiotically; 4) Full penetrance alleles, which possess 40 or more repeats 
(that might be up to ~250 CAGs) and also are meiotically unstable[39,40]. 
 
 
Figure 1 – Classification of alleles depending on HTT’s CAG repeat size. 
 
There have been reports of possible HD diagnosis in individuals with repeats in 
the higher-end of the unaffected range (i.e. large intermediate alleles)[41,42], but most 
of them do not show convincing evidence that the phenotype observed is 
consequence of HTT’s CAG repeat size[41]. There is also discussion if a single 
reported case for a specific allele size is enough to lead toward changes in 
classification[43]. Additionally, the existence of HD phenocopies is known, and while 
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for several of them genetic causes have been described[44–48], a majority has no 
known causal gene[49] as of yet, possibly explaining some of these rare cases.  
Nonetheless, standardized guidelines are of extreme importance, as they 
assure that individuals with comparable repeat sizes get homogenous genetic 
counseling and disease risk assessment[39,40,43]. 
1.7. CAG repeat length and HD age-of-onset 
The mean age-of-onset for the disorder is 45 years of age, but onset might also 
occur very early or very late in life[24]. Concomitantly with the discovery of the gene, 
a potential inverse correlation of repeat size with HD age-of-onset was observed, with 
large repeats resulting in the juvenile form of the disorder (Figure 2)[19].  
 
Figure 2 – Relationship between CAG repeat size and age-of-onset. Adapted from [14]. 
 
This correlation has been confirmed multiple times in several 
cohorts[14,24,33,35,50,51]. CAG repeat size accounts for ~56% of age-of-onset 
variation in HD[14,24,33–35,51,52]. A considerable part of the remaining variability is 
heritable, implicating a role for other genetic contributors, although environmental 
factors also play a part[16,18,51,53].  
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Early on, the search for genetic components contributing to the residual 
variation of age-of-onset relied on candidate regions or genes, including the size of 
the normal allele in heterozygous individuals, or genes related to neuronal pathways 
and neurodegeneration (such as GRIK2 and PPARGC1A), but this approach has not 
provided results that convincingly withstand rigorous statistical scrutiny[24,51]. 
Recently, using an unbiased approach through a genome-wide association study 
(GWAS). Three main distinct loci were identified as modifiers of residual age of motor 
onset, contributing to hasten or delay the phenotype, implicating different clusters of 
pathways, among them DNA repair[54] leading toward the search of modifier genes 
using a more data-driven approach. 
1.8. Intergenerational instability of the CAG repeat in humans 
Changes in the number of repeats in parent-offspring transmissions were 
identified immediately upon the discovery of the expanded CAG repeat in HTT as the 
genetic cause for HD[19]. Intergenerational instability of the repeat is partly 
responsible for the earlier onset in successive generations – anticipation – of the 
disorder[7,55,56]. It is also responsible for changes from intermediate repeat sizes into 
disease associated alleles, as well as changes from reduced penetrance CAG sizes 
into fully penetrant alleles[37,57,58]. The latter also explains some “sporadic” HD 
cases (where there was no previous familial history of the disorder) where these de 
novo mutations happened due to allele expansion in an unaffected parent[19] that may 
amount to up to 8% of the diagnosed cases[24].  
Among individuals with expanded repeats, ~70-80% of transmissions are 
intergenerationally unstable[33,38,56,59,60], with maternally transmitted repeats 
being stable or leaning towards contractions, while transmissions through the paternal 
germline are less stable – including at lower repeat sizes as briefly mentioned 
previously (Figure 1) – and usually tend towards expansions[33,55,56,59–64]. 
Furthermore, most very large alleles, associated with juvenile-onset HD, usually 
emerge from paternal line inheritance[4,65]. Besides parental sex differences, repeat 
size also influences intergenerational instability, with longer CAG repeats having a 
tendency toward a higher frequency and larger TNR changes[33,56,60,63,64].  
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HD families show clustering of transmitted repeat size changes, indicating the 
presence of possible genetic modifiers of intergenerational instability[60,64]. 
Regarding possible cis-modifiers, a specific 4p16.3 haplogroup of 22 single nucleotide 
polymorphisms (SNPs), has been associated with the change of intermediate-sized 
alleles into disease range alleles[66], though later studies with a larger cohort showed 
no relationship between haplotypes (related to the haplogroup) with the size of the 
expanded CAG or with intergenerational instability[50,67]. Segregation of instability 
within the very large Venezuelan pedigree, which has its origin in a single founder and 
shares a single 4p16.3 HTT haplotype also raises the possibility of trans-effecting 
modifiers altering intergenerational instability[60]. Furthermore, other possible 
modifiers – such as parental age, offspring sex, and repeat size of the normal allele in 
heterozygotes – of TNR length changes across generations have been proposed, with 
mixed results regarding an actual modifying role[52,56,60,63,68]. 
1.9. Somatic instability of the CAG repeat in humans 
Somatic instability of the CAG repeat was early identified in multiple tissues 
from patients, with most brain areas showing a higher degree of instability when 
compared with peripheral tissues[69]. Moreover, among brain regions, the striatum 
presented the largest changes – noticeably trending toward expansions – while the 
cerebellum showed the highest stability[69]. Early on, this lead to speculation that glial 
cells, very prominent in most brain regions when compared to the densely neuron-
packed cerebellum, might be more prone to repeat changes and partially explain these 
differences[69]. Later observations comparing grey matter (neuron enriched) and 
white matter (glia enriched) showed the opposite, with predominantly neuronal matter 
showing larger repeat changes[70]. Laser capture microdissection of individual cell 
types confirmed this higher susceptibility of neurons to larger expansions[70].  
Using techniques such as small-pool PCR, that capture CAG size changes at 
higher resolution, even more frequent and larger changes in TNR size were 
discovered in patients’ brain tissue, namely in the striatum of individuals showing the 
earliest stages of the neuropathological process[71]. These differences in instability 
were lost when looking at striatal tissues in brains at higher grades of pathology. This 
indicates that the aforementioned changes may be present early in the disorder and 
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might not be observed later due to earlier neuronal death and striatal atrophy caused 
by these large expansions; notwithstanding these alterations are still measurable in 
other structures such as the cortex[70,71]. Taking into account that large changes are 
already present in brain tissue at early stages of the disorder, there is a possibility they 
may precede and even affect HD symptoms[70,71]. In agreement with this hypothesis, 
the evaluation of a cohort of individuals presenting either very early or very late ages-
of-onset, matched for inherited allele sizes, showed distinctively different distributions 
of expanded repeats, with individuals with lower ages-of-onset presenting higher 
maximum expansion values and overall higher relative frequency of large 
changes[72]. These expansion-trending profiles might therefore be precipitating 
disease and potentially explaining the earlier than expected onset[24,72].  
Other cell types have also been studied in order to better understand and 
characterize somatic instability[34,73,74]. Buccal cell DNA from individuals with 
expanded alleles showed that repeat size affects expansion frequency[73] similarly to 
what was initially proposed in brain tissue[69].  While originally, lymphoblasts from 
patients were reported to show no instability[75], later studies have reported a limited 
but existent instability after a determined TNR threshold[74]. 
1.10. Model systems of HD 
Many model systems have been created and used to study HD, among them, 
yeast, roundworm, fruit fly, zebrafish, numerous mice, rat, pig, sheep, rhesus 
monkeys, and human derived cell models, such as lymphoblastoid cell lines and 
induced pluripotent stem cells (iPSCs). Different models have their own limitations and 
advantages and the most appropriate model is dependent on the goal and object of 
study[76]. 
By far, most models developed for HD are murine models, and were created by 
a plethora of techniques and encompass wide-ranging repeat sizes[76]. Among the 
most utilized models for HD are knock-in models (HttQ20-HttQ175)[77–80] and 
transgenic mice expressing N-terminal fragments of huntingtin with expanded polyQ 
tracts (R6)[81].  
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Knock-in mice are genetically accurate replicas of the human mutation, 
presenting one wild type allele (of mouse Htt) and one humanized allele in its proper 
sequence context[77–80]. HttQ111, HttQ140 and HttQ175 have been thoroughly 
characterized in terms of behavioral changes, showing reduced activity in the dark 
phase, coordination and motor learning deficits, gait impairment, and reduced 
sensitivity to odors, among other phenotypes[79,80,82–84]. Neuronal inclusions, 
neurodegeneration and gliosis are also observed in knock models at high repeat 
sizes[85–87]. While N-terminal truncated models tend to have an extensive 
degenerative phenotype with a fast onset of motor, cognitive and behavioral symptoms 
and a shortened lifespan[81]. Both knock-in and transgenic models show 
intergenerational repeat sizes changes as well as somatic instability, making them 
useful tools in characterizing CAG repeat instability. 
1.11. Intergenerational instability in mouse models 
Alterations in CAG repeat size across generations is also observed in many 
mouse models of HD[78–81] and many factors have been observed to influence this 
intergenerational instability.  
Parental sex is a big determinant of changes, with paternal transmissions 
preferentially expanding while maternal transmissions most commonly show 
contractions[78,88,89]. Offspring sex was also proposed to influence intergenerational 
repeat changes, and while instability was similar in embryos of both sexes, male 
embryos showed higher frequency of changes towards increases in repeat size, while 
female embryos tended toward contractions[89]. Parental age does not appear to 
influence intergenerational TNR size alterations in knock-in models[78]. Larger 
parental repeats have been shown to result in more frequent repeat length 
changes[78]. Cis-acting factors and genomic context are also thought to play a role in 
intergenerational instability as transgenic mice with distinct insertion sites for the 
repeat show very observable differences in parent-to-offspring stability[81]. HttQ111 
knock-in mice with different background strains suggest a role for genetic background 
and trans-acting factors in parent-offspring repeat size changes, and indeed genes 
have been shown to modulate intergenerational instability, namely Msh2, Msh3, Msh6, 
and Neil1[90–92]. 
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1.12. Somatic instability in mouse models 
Somatic variation in CAG repeat was identified in the commonly used HD 
mouse models[78,81]. The tissue specificity of instability is concordant in most models, 
with high instability in striatum (similarly to what was observed in patient post-mortem 
brains) and liver, while other organs and tissues such as tail, heart, spleen and 
cerebellum showed higher stability[78,81,91,93–96].  
Somatic instability was shown to depend on repeat size, with longer repeats 
showing increased instability[78]. Somatic repeat size changes highly correlate with 
age, with changes prone to larger and more frequent expansions[96–98]. Age 
dependence has also been observed in fully differentiated cells indicating non-
replication pathways are involved in instability[99,100]. Transgenic mice models (R6) 
with distinct insertion sites for the repeat have shown that genomic context alters 
repeat stability independently of the tissue analyzed[81]. Genetic background effects 
have been described to alter somatic instability with knock-in mice in the 129 strain 
showing decreased striatal instability when compared to mice in B6 and FVB 
strains[91,101]. Modifiers of somatic CAG repeat instability have been identified using 
mouse models for the disorder[90,92,102,103]. Linkage mapping lead to the 
identification of Mlh1 as the modifier responsible for the differences in striatal instability 
between B6 and 129 strains. This discovery was validated through crossing knock-in 
HttQ111 mice with knock-out Mlh1 mice, where all expansions were eliminated in the 
striatum and liver[102]; and crosses with Mlh3 knock-outs showed the same 
consequences[102]. Crossing HttQ111 with expanded repeats had also previously 
identified other modifiers of striatal instability, namely Msh2[90] and Msh3[104]. 
Crosses with R6/1 mice have been used for the same purpose, identifying Neil1 and 
Ogg1 as modifiers[92,105]. Functional polymorphisms in the Mlh1 and Msh3 may 
mediate the role of this machinery in repeat instability[102,103]. Furthermore, other 
approaches have been used to identify candidates of instability modulation, namely 
through the evaluation of genes differentially expressed in stable versus unstable 
tissues (such as cerebellum versus striatum)[106,107]. 
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Having all of the previously mentioned information in mind, the projects 
presented in this thesis have different specific goals, and have focused on different 
HD models, containing both experimental and data analysis components, but share 
the global objective of finding factors that influence CAG repeat instability, so that this 
biological phenomenon might be better understood, and might one day be a pathway 
toward a therapeutical possibility for patients and carriers of the expanded HTT CAG 
repeat. 
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2. CAG repeat instability in human 
lymphoblastoid cell lines (LCLs) and germ 
line
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2.1. Introduction 
While a typical presentation of HD starts in adult life, with a mean onset at 45 
years of age, the disorder’s age-at-onset is highly variable and may start in early 
childhood or late in life[14,52]. CAG length has a strong relationship with age-at-onset 
and may explain up to 70% of variance regarding disease onset age[14]. Given this 
relationship, it is important to consider the role of parent-to-offspring changes in repeat 
size, which have been observed to occur more frequently in paternal transmissions 
and trend toward expansions[56,60,63,64,75], partially explaining the genetic 
anticipation seen in the disorder[55,62]. 
Nonetheless, factors other than inherited repeat size are at play, as even 
considering two individuals with a similar CAG size, their age-at-onset might vary up 
to 20 to 25 years[51], although this variation also has heritable components, indicating 
the presence of modifier genes[14]. Taking this into account, efforts have been made 
to identify these modifiers; notably a large GWAS studying modulators of this residual 
age of motor onset (variation of age-at-onset non-dependent on CAG size effect)[54]. 
This study identified loci associated with residual age-at-onset, some of them 
containing genes related to DNA repair machinery, such as MLH1 and FAN1. 
Furthermore, association analyses among pathways were also performed and three 
stood out oxido-reductase activity, mitochondrial fission, and DNA repair[54].  
Interestingly, the modifiers of somatic instability identified in mouse models of 
HD are DNA repair genes[90,102–104], and in patients it was shown that higher levels 
of somatic instability (namely somatic expansions) have been associated with younger 
age of disease onset, raising the possibility of somatic instability being an intermediary 
in the relationship between age-at-onset modulation and the results mentioned above. 
Additionally, natural occurring SNPs between mouse strains (namely in Msh3, and 
Mlh1) have been proposed to be responsible for this instability modulation[102,103]. 
Mouse models have also given us some clues about possible relationships 
between somatic and intergenerational instability. Increasing CAG repeat sizes in 
knock-in models show both higher levels of intergenerational and somatic 
changes[78–80]. In early evaluations within the transgenic R6 models presenting no 
  
25 
 
somatic instability also appeared to show more limited intergenerational changes[81]. 
Regarding trans-acting factors most, but not all, seem to modulate both 
intergenerational and tissue CAG changes[90,102,104]. There is considerable 
evidence of possible overlap between somatic and intergenerational instability in mice 
models but in humans the relationship is of yet unknown, but would be important to 
assess as one might be able to assess if shared mechanisms are present, and 
therefore find ways to modulate/prevent both types of instability at once. 
While mouse models have been of great importance to study the disorder in 
general, instability and instability modifiers in particular, human models for instability 
assessment and characterization are still limited, with some efforts made with 
lymphoblastoid cell lines (LCLs)[74] and iPSC models have been successfully used in 
other repeat disorders[108]. 
With all of this in mind this chapter contains several projects related to LCL 
instability and intergenerational/germline instability: 1) LCLs derived from four patients 
within a nuclear family presenting an unusually high level of intergenerational 
instability were studied in order to assess if there might be an unusually high level of 
somatic instability in the transmitting parent, as well as to characterize if/how cell 
culture and passages might influence repeat size, and evaluate the potential of these 
cell lines as human-derived models for instability studies; 2) assess possible 
relationships between somatic and germline instability through the evaluation of 
instability, expansion and contraction indexes in LCLs and sperm of individuals within 
a specific CAG size range; 3) analyze the genetic association of a MLH1 marker 
(rs1799977), situated in one of the candidate regions identified in the age-at-onset 
modifier GWAS, with the three measures of instability in LCLs and sperm samples; 4) 
using instability data from a series of LCLs spanning a large range of CAG repeat 
sizes, and RNA-seq expression data of DNA repair machinery genes, provide data-
driven and hypothesis-generating candidate instability modifiers based on correlations 
of instability values and expression of DNA repair genes. 
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2.2. Methods 
2.2.1. Cell culture 
The LCL culture here described, pertains only to the nuclear family poject 
mentioned above and were grown as part of the core facility at the Center for Genomic 
Medicine (CGM), Massachusetts General Hospital (MGH). 
Lymphoblastoid cell lines (LCLs) were cultured in Gibco™ RPMI Medium 1640 
(ThermoFisher Scientific) with 10% penicillin-streptomycin (10,000 U/mL, 
ThermoFisher Scientific) at 37 °C. Media was replaced on average every 2-3 days, 
and cells were passaged on average every 5-7 days, and in every passage one pellet 
was collected and frozen at -80 °C for subsequent DNA extraction. Cultures were 
maintained for a total of 2-3 months and, in total, pellets from thirteen passages were 
collected.  
2.2.2. LCL DNA extraction 
DNA was extracted using a modified version of the 5 PRIME (Fisher Scientific) 
Manual ArchivePure DNA Purification methodology followed by a standard phenol-
chloroform extraction. Pellets were thawed on ice and 300µL of Cell Lysis Solution (5 
PRIME) and 5µg of Proteinase K were added, followed by mechanical homogenization 
of the solution and a 3-4h incubation at 50 °C. Afterward, in a fume hood, 300µL of a 
phenol:chloroform:isoamyl alcohol (25:24:1, v/v) were added, followed by a vortex 
solution homogenization, and samples were then centrifuged at 13000 rpm for 5 min. 
The aqueous top layer was transferred to a new tube and ~1 volume of chloroform 
was added followed by a 2 min centrifugation at 13000 rpm. The top layer was again 
transferred to a new tube, sodium acetate was added to a final concentration of 0.3M, 
followed by 600µL of absolute ethanol and homogenization was performed by manual 
inversion (15 to 20 times) and centrifuged at 4 °C, 15000 rpm, for 30 min for DNA 
precipitation. Supernatant was discarded and DNA pellets were washed two times with 
70% ethanol followed by a 2 min centrifugation at 13000 rpm. Ethanol supernatants 
were discarded. Samples were left to air dry for 20-30 minutes and were then 
solubilized in TE buffer. 
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DNA concentration was determined through spectrophotometry using a 
Nanodrop 1000 and afterward diluted to 40ng/µL for downstream use. 
LCL samples and all the sperm samples utilized in the somatic and germ line 
instability study were available at a DNA solution stage, and had been sized with a 
standardized assay for CAG length, consequence of previous large collection of 
samples by the Gusella and MacDonald groups at the CGM and access to these 
samples was kindly provided to us.  
2.2.3. Fragment analysis and instability calculation 
Fragment analysis was performed to evaluate instability, starting with a 
polymerase chain reaction (PCR) of the sequence containing the expanded repeat. 
PCRs were performed using the Taq PCR Core Kit (Qiagen) where each reaction 
contained 1x PCR buffer (Qiagen), 20% Q-solution (Qiagen), 16 nmol of HU3 (5' 
GGCGGCTGAGGAAGCTGAGGA 3') and  labelled CAG1 (5' 6-FAM-
ATGAAGGCCTTCGAGTCCCTCAAGTCCTTC 3') primers, 4 nmol of dNTPs and 0.5 
units of Taq in a final volume of 20µL. Cycling conditions were as follows, 95 °C 5min, 
30 cycles of 94 °C 30sec ,65 °C 30 sec, 72 °C 90sec, followed by 10 min at 72 °C. 
Products were then subjected to capillary electrophoresis in an ABI 3730 (Applied 
Biosystems) sequencer. Electropherograms were analyzed with GeneMapper 
Software v5.0 (Applied Biosystems) undergoing rigorous quality control and validation.  
Instability was determined using a method previously described[93], in short: 
the PCR reaction generates multiple-sized products that when analyzed in 
GeneMapper appear as a cluster of peaks differing from each other by one CAG 
repeat unit, and peak height is assumed to be proportional to the number of alleles 
containing a specific repeat size; the peak containing the highest signal is considered 
the “main allele”; alleles to the right are considered expansions and alleles to the left 
contractions; heights for all alleles of interest are extracted and individual peak heights 
are normalized to the sum of all heights; normalized peak heights are then multiplied 
by a factor determined by the change/distance to the main allele (e.g. for an allele 1 
CAG smaller than the main allele this factor is -1, for an allele 2 CAGs larger the factor 
is 2, and so forth); the values stemming from this calculation are then added together 
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generating the instability index. Expansion and contraction indexes can also be 
determined, adding only the peaks to the right or left of the main allele. 
In this study, slight changes to the methodology were applied; instead of adding 
a relative threshold (e.g. 20% height of the main allele) as described in the original 
method[93], an absolute threshold of 50 for minimum peak height was applied, and 
alternatively to the instability index, an absolute instability index – consisting of the 
sum of the expansion index and the absolute value of the contraction index – was 
calculated. 
2.2.4. RNA-seq data 
RNA-seq data was acquired from a collaboration with other groups at the CGM 
and was acquired as described in [109]. 
2.2.5. Statistical analyses 
Ordinary least squares regressions for evaluation of relationships between 
CAG repeat size and instability measures (absolute instability, expansion index and 
contraction index) were performed in Microsoft Excel 2013. Possible correlations 
between somatic (LCL) instability and germ line (sperm) instability were also analyzed 
through the same regression method and software. Genotypic association analysis of 
instability was evaluated through linear regression using SPSS Statistics 20 (IBM). 
Residual values of absolute instability, expansion and contraction indexes were also 
calculated with SPSS Statistics 20. Pearson correlation values between residuals and 
gene expression values were also calculated in the same software. To control for 
multiple testing the Bonferroni correction was applied to significance levels when 
appropriate.  
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2.3. Results 
2.3.1. LCL instability in a nuclear family presenting intergenerationally 
unstable HTT CAG repeat transmissions 
The nuclear family, of American origin, analyzed in this study consisted of an 
affected father, originally determined to have a repeat with 42 CAGs, an allele on the 
low end of fully penetrant sizes, while his offspring showed much larger CAG repeat 
sizes in the range of 80 to 139 repeats (Figure 3). Therefore, he showed a very high 
propensity for large intergenerational repeat size changes. 
 
Figure 3 – Pedigree and HTT CAG repeat information in the nuclear family in study 
 
Detailed bar-plots depicting relative allele frequency for all passages and for all 
lines are presented in Figure S1 to Figure S4. For added clarity of interpretation they 
are shown in increasing order for the individuals’ main allele size (i.e. I-1, II-3, II-1, II-
2). For a simplified view of repeat length changes heat maps depicting the relative 
abundance of each allele size per passage are presented (Figure 4 to Figure 7), 
following the same order mentioned above, for consistency and clarity. 
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Figure 4 – Relative signal height (%) per allele in each passage in individual’s I-1’s LCLs. 
Underlined values show the highest abundance allele within a population. Green indicates a low 
abundance, yellow and orange intermediate and red highest for each passage. 
 
 
 
Figure 5 – Relative signal height (%) per allele in each passage in individual II-3’s LCLs. 
Underlined values show the highest abundance allele within a population. Green indicates a low 
abundance, yellow and orange intermediate and red highest for each passage. 
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Figure 6 – Relative signal height (%) per allele in each passage in individual II-1’s LCLs. Underlined values show the highest 
abundance allele within a population. Green indicates a low abundance, yellow and orange intermediate and red highest for each passage. 
 
  
 
 
Figure 7 – Relative signal height (%) per allele in each passage in individual II-2’s LCLs. Underlined values show the highest 
abundance allele within a population. Green indicates a low abundance, yellow and orange intermediate and red highest for each passage. 
Green indicates a low abundance, yellow and orange intermediate and red highest for each passage. Grey bar replaces the 70-93 CAG 
interval, where no alleles were found. 
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Overall, mosaicism is observed in all four LCLs studied, although to very 
different extents.  
The affected father (individual I-1), showed the lowest CAG repeat size – 
(always) consistent at 51 CAGs – and the tightest range of allele sizes, seemingly 
becoming more constricted as the number of cell passages increased (Figure 4). The 
offspring bearing the lowest CAG repeat size (individual II-3, 81 CAGs, Figure 5), 
showed the same tendency for the main allele size to stay consistent throughout 
passages. Nonetheless, the presence of a second allele population (Figure S2, P2-
P10) is noticeable in early passages but eventually dwindles in later passages (Figure 
S2, P11-P13).  
LCLs of the two other offspring show much more complex behavior. LCLs from 
individual II-1 initially showed allele sizes in three main sets (~103, ~112, ~122 CAGs, 
Figure 6), probably representing 3 cell populations bearing those sizes. Throughout 
passaging, the LCLs show an intricate pattern of CAG size distribution, with the 
population with the highest size showing an increasing prevalence during most 
passages (Figure 6, Figure S3 P1-P8), with a steep decrease, to complete non-
representation in the last studied passage (Figure 6, Figure S3 P13), where the most 
common allele size is 108 CAGs. Interestingly, if we follow the most prevalent allele 
per “population” and per passage (Figure 6, underlined), we see a mostly steady trend 
moving toward larger allele sizes. In II-2’s LCLs this trend is clearly observed in the 
largest allele size population whose main allele starts at 141 CAGs (Figure 7, Figure 
S4) and in the last observed passage stands at 153 CAGs (a ~1 CAG average 
increase per passage in main allele size). This LCL also started with 3 main sets of 
alleles (at ~100 and 116 CAGs in addition to 141, Figure 7, Figure S4), but the smaller 
sizes populations were not observed after approximately half the passages (P6). Of 
note is the overall minor but increasing presence of an allele population at ~67 CAGs 
(starting at P8, Figure 7, Figure S4) in a range that was not observed in any of the 
previous passages and much smaller than the any of the alleles initially present.  
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2.3.2. Relationship between LCL and germline instability 
To better assess a possible relation between somatic and germ line instability, 
DNA samples from LCL and sperm samples of a set of 19 individuals showing 
expanded alleles within a restricted CAG repeat size range (41-45 CAGs) was 
evaluated. 
After absolute instability, expansion and contractions indexes were calculated, 
possible correlations with CAG repeat size were evaluated (Figure S5 to Figure S7), 
as previous studies have shown dependency of instability with CAG repeat 
size[69,73].  
In LCLs, no correlation was apparent (absolute instability: R² = 0.0473; 
expansion: R² = 0.0601; contraction R² = 0.0015, Figure S5), while sperm samples 
appear to show a higher correlation (absolute instability: R² = 0.2223; expansion: R² = 
0.2078; contraction R² = 0.2721, Figure S6). One of two possibilities might explain this 
difference; either higher CAG sizes are driving higher instability, or instability levels 
are so widespread that the most frequent allele (taken as the main allele), might no 
longer match the inherited repeat size and that change is driving the correlation. Since 
we are using a set of samples where we also have repeat sizing in LCLs, which are 
more stable than male germ line cells, and may be a better indicator of the modal allele 
in the population of PCR products, these correlation levels were re-assessed using 
the CAG size in the LCLs. In this scenario no correlations were observed (absolute 
instability: R² = 0.0113; expansion: R² = 0.0094; contraction R² = 0.0330, Figure S7), 
probably indicating that the previous observation stemmed from high instability levels 
changing main allele size driving the correlation levels up in germ line cells.  
Therefore, considering that in this range the effect of CAG on the measures of 
instability we are using is minimal or non-existent, and that LCL and sperm samples 
compared come from the same individual, we went on and evaluated possible 
correlations between instability indexes (Figure 8 to Figure 10). 
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Figure 8 – Absolute instability in LCLs and germ line 
 
 
Figure 9 – Expansion index in LCLs and germ line 
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Figure 10 – Contraction index in LCLs and germ line 
 
Interestingly, these preliminary analyses show that LCLs and sperm cells 
present a correlation of absolute instability (R² = 0.3433), apparently driven by a highly 
correlated expansion index (R² = 0.779), while contraction indexes seem to show no 
relationship (R² = 0.0001).  
2.3.3. Testing the association of rs1799977 (MLH1) with instability in LCL 
and germline samples 
Using the samples from the project mentioned above (as the 19 individuals had 
been selected having into account their rs1799977 genotype, obtained as part of the 
previously mentioned GWAS, for this segment of the project), we also evaluated their 
instability’s relationship with the individuals’ genotype for a marker present in one of 
the main regions identified to influence residual age-at-onset. 
Association was evaluated through regression analysis for both additive and 
dominant effects. Representations of absolute instability evaluation in LCLs using 
either the additive and dominant models are represented in Figure 11.  
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LCL 
  
Figure 11 – Absolute instability per rs1799977 genotype considering an additive effect model 
(left) and a dominant effect model (right). 
 
The evaluation of possible associations between rs1799977 genotype and 
absolute instability, expansion and contraction indexes showed no significant 
associations (Table 1). 
Table 1 – Significance values for association analysis between rs1799977 genotypes 
and absolute instability, expansion and contraction indexes. 
  Regression p-value 
  
Additive 
effect model 
Dominant 
effect model 
LCL 
absolute instability 0.582 0.236 
expansion index 0.886 0.705 
contraction index 0.526 0.199 
Sperm 
absolute instability 0.829 0.684 
expansion index 0.769 0.626 
contraction index 0.507 0.582 
 
Therefore, thus far we may suggest that rs1799977’s genotype does not seem 
to be responsible for alterations in instability levels in LCLs or germ line, in a very 
limited sample that might not possess enough statistical power or be fully 
representative a possible effect in a larger number of patients, and should therefore 
be expanded to include a larger number of individuals. 
2.3.4. Search for instability modifiers using human LCLs 
In a separate set of LCLs from 24 individuals with a range of CAGs (pertaining 
to the longer allele size) spanning all the way from normal alleles to very large alleles 
generally associated with the juvenile form of the disorder (17 to 82 CAGs), instability 
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assessments were performed and indexes calculated for each line. Taking advantage 
of RNA-seq data from the same lines also being available, expression data from 118 
genes (Table S1) involved in numerous pathways related to DNA damage response, 
repair, and recombination, potentially involved in instability modulation, were analyzed 
to assess and prioritize possible candidates in a human derived cell model. 
Once again, we first evaluated possible correlations between main CAG repeat 
size and instability levels. We observed that this expanded range absolute instability 
and the contraction index present high correlation coefficients with CAG size (absolute 
instability: R² = 0.8375, Figure 12; contraction index: 0.8701, Figure 14), while 
expansion index presents a milder correlation value (R² = 0.69, Figure 13). 
 
 
Figure 12 – Absolute instability variation with CAG size in LCLs 
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Figure 13 – Expansion index variation with CAG size in LCLs 
  
 
Figure 14 – Contraction index variation with CAG size in LCLs 
 
This is an important observation, as it indicates that direct analyses of instability 
indexes, could be heavily confounded and/or determined by CAG repeat size.  
Indeed, if we took these analyses forward as is, testing for significant 
correlations between gene expression and CAG size, absolute instability, expansion 
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or contraction indexes, we see that the expression of 30 genes has a nominal 
significant correlation with CAG size, while 15 have a relationship with absolute 
instability, 8 with the expansion index and 28 with contraction levels (Table S2; Table 
S3), but all genes related to absolute instability and expansion indexes are included in 
the CAG correlated set and only 5 genes correlated with contraction index do not follow 
this trend (Figure 15). 
 
 
Figure 15 – Overlap of genes correlated with CAG repeat size (teal) and absolute 
instability (A, grey), expansion index (B, red) and contraction index (C, green) 
 
Therefore, a different approach was taken, calculating linear regressions’ 
residuals from the relationships of CAG size with absolute instability, expansion and 
contraction indexes, determining values of “CAG-independent instability”, and 
studying their correlation with gene expression. 
In these analyses 25 genes showed nominally significant (p<0.05) or significant 
(p<0.0004 significance threshold after Bonferroni correction) correlations between 
their expression and CAG-independent instability/expansion/contraction (Table 2).  
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Table 2 – Significant and nominally significant correlations between absolute instability, 
expansion and contraction residual values and gene expression. 
Absolute instability residual  Expansion index residual Contraction index residual 
Gene Correlation p Gene Correlation p Gene Correlation p 
TP73 -0.632 0.001 TP73 -0.556 0.005 NTHL1 0.754 <0.0004 
RPA3 -0.431 0.036 SSBP3 0.434 0.034 POLD1 0.670 <0.0004 
SSBP3 0.419 0.042       RAD23A 0.627 0.001 
            MDM2 -0.590 0.002 
            SWSAP1 0.549 0.005 
            FAN1 -0.549 0.005 
            TDP2 -0.528 0.008 
            LIG1 0.506 0.012 
            SPEN 0.505 0.012 
            LONP1 0.500 0.013 
            STRA13 0.490 0.015 
            MCM7 0.476 0.019 
            DMC1 0.474 0.019 
            IGHMBP2 0.469 0.021 
            C10orf2 0.452 0.027 
            MSH5 0.447 0.028 
            SSBP4 0.446 0.029 
            NABP1 -0.446 0.029 
            POLD2 0.443 0.030 
            TREX1 0.443 0.030 
            ATM -0.424 0.039 
            ERCC4 -0.421 0.040 
 
Only two comparisons were significant after multiple testing correction; NTHL1 
and POLD1, both as modulators of contraction index CAG-independent instability, with 
lower levels of expression relating to more prominent contractions. Among other 
nominally significant correlations there are some interesting results, such as TP73, 
which shows significance with both absolute instability and expansion index, with 
higher levels of gene expression protecting against expansions. TP73 retains its 
significance in absolute instability when only individuals with 35 CAGs and over are 
considered (Table S4). Among the genes related to alterations in contraction index, 
two others, FAN1 and LIG1, are of special interest, with LIG1 expression showing a 
behavior not unlike NTHL1 and POLD1, while higher FAN1 levels seem to lean toward 
larger contractions (Figure 16). 
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Figure 16 – Relationship between absolute instability (top left) and expansion index 
(top right) residuals and TP73 expression levels, as well as, correlations between contraction 
index residuals and expression levels for NTHL1 (middle left), POLD1 (middle right), FAN1 
(bottom left), LIG1 (bottom right). 
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2.4. Discussion 
In this chapter many characteristics of somatic instability in LCLs, and some 
features of germline instability have been evaluated. These studies were mainly 
exploratory using different ways of evaluating LCL and germ line instability, meant to 
be hypothesis generating tools geared toward guiding and refining further analyses in 
the field.  
Initially, an evaluation of LCL instability in a nuclear family where the father 
(individual I-1) presented a very strong trend to intergenerationally unstable 
transmissions, with changes reaching a difference of almost 100 repeats, and his three 
affected children was performed. This study had two main goals; 1) to work as a 
preliminary indicator of possible higher somatic instability when high levels of 
intergenerational instability are present; 2) to assess how LCLs with very distinct main 
CAG allele sizes behave regarding repeat instability with maintenance and passaging, 
in order to assess the suitability of these cells as human models to search for instability 
modulators (e.g. being used in – possibly high throughput – screening of small 
molecules). 
The somatic cell line of individual I-1 seems to present a fairly high stability, 
with the maintenance of modal allele size. Extended culturing of the LCL seems to 
actually narrow the population variation in CAG repeat size. Considering that the 
individual showed a high propensity for intergenerational instability but a limited LCL 
instability one might argue thus far that there is no relationship between them. 
Regarding the potential to use LCLs as human models for instability and 
instability modulation, efforts have been made previously[74] where very low or no 
instability was reported; even over a  longer culturing time-frame than the one(s) 
presented in this project, only repeats 60 or larger presented repeat size changes[74]. 
Here, we see limited mosaicism at 51 CAGs, in agreement with the previously 
described behavior of LCLs in this repeat length range. Even though we see a larger 
overall spread of allele sizes, we still observe a consistent main allele size in the cell 
line harboring 81 repeats (individual II-3). 
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Nevertheless, we do observe interesting behaviors of relative distributions of 
CAG repeat sizes and instability in LCLs, when analyzing the cell lines from the 
offspring with over ~100 CAGs (individuals II-1 and II-2), showing that there is indeed 
a dependence of instability with repeat size.  
The two lines with higher CAG sizes show some common and some disparate 
characteristics. Both of the lines appear to show high levels of mosaicism, with three 
different populations of alleles, probably due to the presence of three main cell 
populations in early passages. In individual II-2’s LCLs the two smaller populations (at 
~100 and 116 CAGs) dwindle and eventually disappear, possibly indicating that 
lymphoblasts with larger CAG repeat sizes may have some growth advantage in 
culture when compared to others with smaller CAGs. In individual II-1 we actually start 
seeing a similar trend but it appears the case is not as straightforward because the 
two smaller populations never actually disappear and come to overtake prominence 
at P11, while the larger size population quickly fades from the culture.  
Another remarkable shared feature can be observed, very clearly in II-2’s LCLs, 
and prominently, after careful evaluation, in II-1’s cell line, which is the slow and steady 
increase in CAG size within a specific population, regardless of whether the population 
itself is becoming more prevalent overall or if it is declining. This shows that LCLs with 
long repeats exhibit a trend toward higher repeat sizes within a population, but not 
necessarily when considering distinct populations. 
The feasibility of using LCLs as human derived cell models to study instability 
seems highly unlikely given the scenarios observed in this project, due to several 
aspects: 1) the cell line with the repeat size closer to the most common sizes in 
patients did not display enough instability to serve as a proper instability model, with 
no apparent repeat changes over thirteen passages; 2) even the relatively larger 
repeat size at 81 CAGs did not show a noticeable change in main allele repeat size, 
and while a second set of alleles seems to be arising in that line we cannot conclude 
it is due to instability and repeat size change, it might just be an effect of a pre-existing 
population with low initial representation that rises for a limited time-frame, 
confounding the results if any other treatment or screening were to be performed at 
the time; 3) noticeable instability was only observed when LCLs with very rare, very 
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long, alleles were present and even then there isn’t a unifying behavior that would 
allow a proper screening for modulators, as a multitude of populations bearing distinct 
repeat sizes are present, and do not seem to act similarly, with peculiar changes in 
the dominant population and modal allele size as well as possible large jumps, that 
are hard to attribute to anything other than random/stochastic effects hard to control 
for. Solutions for most of these problems are possible, but cumulatively require a multi-
level, high effort, controlled environment, including: the initial “seeding” of a very low 
number of cells, insuring only one main and matching population of alleles is present 
at the start for both treated and control cultures, which would be very difficult to 
achieve; the insurance of similar growth levels in both scenarios, which would 
implicate increased handling and disturbance of the cell cultures; strictly paired 
technical aspects such as matched feeding, culturing, splitting, pellet collection, and 
feeding stages in order to minimize variability between treatment and controls would 
be required. All of this put together would defeat the overall purpose of using LCLs 
which would have been to acquire an easy and quick to use human-derived cell model 
to evaluate somatic instability. 
Even though in the previous project, the hypothesized relationship between 
intergenerational and somatic instability (in LCLs, which are relatively stable) did not 
seem apparent, a single observation in one individual is insufficient to draw strong 
conclusions on their relationship. Therefore instability in LCLs and germline (sperm) 
cells of 19 individuals bearing a very restricted range of CAG repeat sizes was 
compared.  Firstly, we saw that in the strict CAG repeat size range considered, 
correlation with instability was non-existent in LCLs and germline, therefore no CAG-
driven effects should be present in the analysis. This time a modest but noticeable 
correlation between absolute instability in LCLs and sperm was observed, which 
seems to be driven by a strong correlation of expansion levels, while contraction 
indexes seem to be unrelated to each other. This is an interesting observation, which 
may indicate that specific genetic background and/or shared mechanisms may 
underlie both somatic and intergenerational expansion. As nineteen individuals might 
be a limited sample to take broad conclusions from, the analysis will be re-performed 
in a larger set of over hundred individuals, in order to validate the relationship observed 
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here. Additionally, a previous study has also reported that higher constitutive CAG 
repeat size from LCLs correlates positively with modal sperm CAG size[60] 
Using the same somatic and germline instability data as above, we evaluated 
the possible role of a MLH1 SNP in these measures. MLH1 was chosen over genes 
in the other significant loci, as mouse model data already indicated that common 
variation in Mlh1 might be responsible for differences in instability between two 
different mouse strains[102]. This marker is part of a block of SNPs identified as one 
of the main candidate regions in modulating residual age-at-onset in HD, and therefore 
it would be interesting to evaluate a possible influence in instability. In this limited 
number of individuals, there does not seem to be a significant correlation of either LCL 
or germline instability with rs1799977 genotype. Again, as a very limited sample it is 
likely not to have sufficient power to identify actual differences and this analysis will be 
re-assessed in a larger sample. Nonetheless, LCLs might not be the best somatic 
tissue to check for instability as a driver for alterations in HD age-at-onset, and studies 
on a more relevant tissue for the disease (e.g. brain), might possibly show a different 
and more accurate relationship.  
The last project focused on the search for genes involved in DNA damage, 
metabolism, and repair whose expression might be related to instability levels 
observed in a set of 24 LCLs, spanning a wide range of CAGs. Our first observation 
was related to a noticeable relation of CAG size and absolute instability, expansion 
and contraction indices, which would result in a high level of multicollinearity, which is 
problematic in regression analyses, and would make overall conclusions hard to 
interpret. Therefore we controlled for this relationship, by extracting the correlation’s 
residuals as they would show the “CAG-independent” instability measures, and 
analyzed their correlation with gene expression. This analysis yielded only two 
significant results after multiple testing correction, namely the genes NTHL1 and 
POLD1 as modulators of contraction. NTHL1 codes for endonuclease III-like protein 
1, a protein involved in oxidative damage repair through base excision repair, and 
POLD1 encodes the catalytic subunit of DNA polymerase delta and is therefore 
involved in DNA replication. Overall, no experimental data so far seems to relate the 
functions of these two proteins, with only a faint hint of a relationship given by putative 
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homologs being co-expressed in other species, therefore their effects are probably 
independent of each other. Looking at other possible modulators within the nominal 
significance values, TP73 is the most significant player related to absolute instability, 
as well as expansions. TP73 codes p73, a protein from the same family as p53, 
participating in apoptotic response to DNA damage, and unlike the modifier genes 
found in mice whose knock-outs ablate expansions, with TP73 higher expression 
levels protecting against expansions. Among the genes showing nominally significant 
association with contractions, two are important to mention: 1) FAN1, which is present 
in one of the loci described in the previously mentioned GWAS shown to modify HD 
age-at-onset. This might indicate that instability may be the mechanism 
interconnecting this association with the change in age-at-onset, in accordance with 
the observation that individuals bearing similar CAG repeat sizes but very disparate 
ages-at-onset also show very different levels of instability[72]; 2) LIG1, which encodes 
DNA ligase 1, involved in DNA replication and also responsible for the ligation step 
(the last one) in the MMR pathway, where other modifiers such as MLH1, MLH3, 
MSH2 and MSH3 act[90,102–104]. Furthermore the mouse homolog of LIG1 has been 
linked to contraction modulation in the CTG repeat in the mouse model of DM1[110]. 
One also has to address that even though all the instability modifiers already 
found were evaluated in this analysis, none of them came out as significant, therefore 
this approach should be further scrutinized to try and understand this disparity, and 
control for other factors such as patient age at collection. Nonetheless, the results of 
this study yielded some interesting results in their “hypothesis generating” capacity, 
giving the genes identified a possible priority position when looking for more instability 
modifying genes in HD models.  
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2.5. Supplementary material 
2.5.1. Supplementary figures 
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
) 
 
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
) 
  Repeat size  Repeat size 
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
) 
 
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
) 
  
Repeat size  Repeat size 
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
) 
 
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
) 
  Repeat size  Repeat size 
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
) 
 
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
) 
   Repeat size  Repeat size 
  
48 
 
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
) 
 
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
) 
  Repeat size  Repeat size 
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
) 
 
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
) 
 
 Repeat size  Repeat size 
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
) 
 
 
 
 Repeat size   
Figure S1 – Bar-plot of detailed relative frequency (%) of each allele size per passage in 
individual’s I-1’s (main allele 51) LCLs. Passage number is depicted on the top left quadrant. 
Column height represents the median relative frequency, error bars represent standard 
deviation.  
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Figure S2 – Bar-plot of detailed relative frequency (%) of each allele size per passage in 
individual’s II-3’s (main allele 51) LCLs. Passage number is depicted on the top left quadrant. 
Column height represents the median relative frequency, error bars represent standard 
deviation. 
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Figure S3 – Bar-plot of detailed relative frequency (%) of each allele size per passage in 
individual’s II-1’s (highest alleles in P1: ~103, ~112, ~122 CAGs) LCLs. Passage number is 
depicted on the top left quadrant. Column height represents the median relative frequency, error 
bars represent standard deviation. 
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Figure S4 – Bar-plot of detailed relative frequency (%) of each allele size per passage in 
individual’s II-2’s (highest alleles in P1: ~100, ~116, ~141 CAGs) LCLs. Passage number is 
depicted on the top left quadrant. Column height represents the median relative frequency, error 
bars represent standard deviation. 
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Figure S5 – LCL instability measures (absolute instability, expansion and contraction 
indexes) by CAG repeat size in the 19 individuals in study. 
 
 
Figure S6 – Sperm instability measures (absolute instability, expansion and contraction 
indexes) by CAG repeat size in the 19 individuals in study. 
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Figure S7 – Sperm instability measures (absolute instability, expansion and 
contraction indexes) by corrected CAG repeat size (taken from the matching LCL) in the 19 
individuals in study. 
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2.5.2. Supplementary tables 
Table S1 – Genes tested for correlation of expression with instability measures 
Genes tested 
ABL1 HMGB1 MSH2 POLD4 RFC1 SWSAP1 
APITD1 HMGB2 MSH3 POLG2 RFC2 SYCE3 
ATM HNRNPA1 MSH4 POLL RFC3 SYCP1 
ATR HNRNPA2B1 MSH5 POLM RFC4 TDG 
BLM HNRNPDL MSH6 POT1 RFC5 TDP1 
BRCA2 HNRNPK MTMR10 PURA RNF212 TDP2 
C10orf2 HSPD1 MUTYH PURB RPA1 TEX11 
CNBP IGHMBP2 NABP1 RAD21 RPA2 TOP2A 
CRY2 KLHDC3 NABP2 RAD23A RPA3 TOP2B 
CTC1 LIG1 NEIL3 RAD23B RPA4 TP73 
DMC1 LIG3 NME1 RAD50 RTF1 TREX1 
ERCC1 LONP1 NTHL1 RAD51 SPEN TRIP13 
ERCC2 LRPPRC OBFC1 RAD51AP1 SPO11 UNG 
ERCC3 MCM4 PCBP1 RAD51B SSBP1 WBP11 
ERCC4 MCM6 PCNA RAD51C SSBP2 WRN 
ERCC5 MCM7 PMS1 RAD51D SSBP3 XPC 
EXO1 MDM2 PMS2 RAD52 SSBP4 YBX1 
FAN1 MLH1 POLD1 RAD54B STRA13 YBX3 
FANCM MLH3 POLD2 RBMS1 STRA8  
FUBP1 MRE11A POLD3 REC8 SUB1  
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Table S2 – Genes whose expression show correlation with CAG repeat size. 
CAG repeat size 
Gene Correlation p 
MTMR10 0.701 <0.0004 
RFC3 0.639 0.001 
PURA 0.604 0.002 
POLD4 -0.573 0.003 
HMGB1 0.570 0.004 
HMGB2 0.565 0.004 
RAD21 0.557 0.005 
MRE11A 0.508 0.011 
SUB1 0.488 0.015 
TOP2A 0.486 0.016 
MUTYH -0.482 0.017 
POLD3 0.466 0.022 
SSBP2 0.463 0.023 
HNRNPA2B1 0.456 0.025 
RTF1 0.449 0.028 
RPA4 0.449 0.028 
TOP2B 0.448 0.028 
BLM 0.440 0.032 
ERCC1 -0.438 0.032 
TDG 0.436 0.033 
CNBP 0.429 0.036 
C10orf2 0.428 0.037 
HNRNPK 0.426 0.038 
ERCC4 0.421 0.040 
SSBP3 0.421 0.041 
RAD51C 0.411 0.046 
MSH6 0.409 0.047 
ERCC2 -0.408 0.048 
RAD51 0.407 0.048 
PURB 0.406 0.049 
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Table S3 – Genes whose expression show correlation with absolute instability, 
expansion and contraction index values. 
Absolute instability Expansion index Contraction index 
Gene Correlation p Gene Correlation p Gene Correlation p 
MTMR10 0.649 0.001 MTMR10 0.582 0.003 MTMR10 -0.673 <0.0004 
PURA 0.585 0.003 SSBP3 0.578 0.003 PURA -0.624 0.001 
RFC3 0.565 0.004 RFC3 0.522 0.009 RAD21 -0.582 0.003 
SSBP3 0.544 0.006 PURA 0.514 0.010 RFC3 -0.562 0.004 
MRE11A 0.474 0.019 RPA4 0.498 0.013 TOP2B -0.557 0.005 
RPA4 0.472 0.020 RTF1 0.448 0.028 ERCC4 -0.542 0.006 
TOP2B 0.468 0.021 HMGB2 0.444 0.030 MRE11A -0.542 0.006 
RAD21 0.463 0.023 C10orf2 0.420 0.041 MUTYH 0.537 0.007 
HMGB2 0.462 0.023       ERCC1 0.531 0.008 
RTF1 0.459 0.024       SWSAP1 0.530 0.008 
TDG 0.458 0.024       TDP2 -0.512 0.011 
HMGB1 0.440 0.031       POLD4 0.511 0.011 
POLD4 -0.436 0.033       ERCC2 0.500 0.013 
ERCC1 -0.418 0.042       TDG -0.499 0.013 
MUTYH -0.411 0.046       HMGB1 -0.498 0.013 
            POLL 0.483 0.017 
            POT1 -0.478 0.018 
            TOP2A -0.463 0.023 
            HNRNPK -0.457 0.025 
            MSH3 -0.454 0.026 
            SSBP2 -0.454 0.026 
            CNBP -0.452 0.027 
            HNRNPA2B1 -0.451 0.027 
            SUB1 -0.432 0.035 
            HMGB2 -0.432 0.035 
            RAD51C -0.421 0.040 
            RTF1 -0.417 0.043 
            SSBP3 -0.416 0.043 
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Table S4 – Genes whose expression show correlation with absolute instability, and 
contraction index residuals considering only individuals with over 35 CAGs. 
Absolute instability 
residual (>35 CAGs) 
Contraction index residual 
(>35 CAGs) 
Gene Correlation p Gene Correlation p 
TP73 -0.507 0.038 NTHL1 0.815 <0.0004 
      SWSAP1 0.761 <0.0004 
      POLD1 0.745 0.001 
      TDP2 -0.698 0.002 
      POLL 0.690 0.002 
      ERCC1 0.617 0.008 
      FAN1 -0.613 0.009 
      MDM2 -0.612 0.009 
      RAD23A 0.607 0.010 
      LONP1 0.605 0.010 
      MCM7 0.593 0.012 
      IGHMBP2 0.577 0.015 
      ERCC4 -0.571 0.017 
      LIG1 0.538 0.026 
      SSBP4 0.534 0.027 
      NABP1 -0.522 0.032 
      TDG -0.520 0.033 
      SPEN 0.511 0.036 
      STRA13 0.495 0.044 
      DMC1 0.490 0.046 
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3. Genetic contributors to intergenerational 
CAG repeat instability in Huntington’s 
disease knock-in mice 
This chapter has been published as: 
João Luís Neto, Jong-Min Lee, Ali Afridi, Tammy Gillis, Jolene R. Guide, 
Stephani Dempsey, Brenda Lager, Isabel Alonso, Vanessa C. Wheeler and Ricardo 
Mouro Pinto. Genetics February 1, 2017 vol. 205 no. 2 503-51
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3.1. Introduction 
Huntington’s disease (HD) is a progressive, degenerative, autosomal dominant 
disorder caused by the expansion of a CAG repeat located in exon 1 of the HTT gene 
(4p16.3), producing an extended polyglutamine tract in the huntingtin protein[19]. 
Alleles over 35 repeats are associated with disease, with 36-39 CAGs showing 
reduced penetrance and 40 or more repeats being fully penetrant[19,111]. The length 
of the expanded repeat is also a major modifier of the age of disease 
onset[33,36,52,55,61,62]. Underlying the variation in inherited CAG repeat length 
between individuals are high rates (~70-80%) of intergenerationally unstable 
transmissions[33,56,59,60,69]. Intergenerational instability of the HTT CAG repeat 
accounts for genetic anticipation seen in HD families[55,56], as well as for changes 
from high normal alleles (27-35 CAGs) to disease alleles (i.e. de novo mutations) and 
transitions from alleles associated with incomplete penetrance to those causing 
completely penetrant disease[37,57,58].  
Mechanisms underlying intergenerational instability are unclear but important 
to understand in order to refine variable estimates of new mutation rates for genetic 
counseling[57,58,112], and for the potential to suppress expansions and/or induce 
contractions. Studies of intergenerational instability in HD families have shown that the 
HTT CAG repeat is strongly biased towards expansions in transmission from fathers, 
while transmissions from mothers have a higher tendency to be stable or 
contract[33,55,56,59–64]. In addition to parent sex, CAG repeat length strongly 
influences intergenerational repeat instability, with longer repeats being more 
susceptible to larger changes[33,56,60,63,64]. Minor effects of offspring sex, size of 
the normal CAG repeat and parental age have also been documented in some but not 
all HD cohorts examined[56,60,63,64,68].  
Clustering of transmitted repeat length changes among HD families implicates 
genetic modifiers of intergenerational instability[60,64]. Familial segregation of 
instability in a large HD Venezuelan pedigree that shares a 4p16.3 (HTT) haplotype 
provides evidence for other genes that can modify instability (trans-acting)[60]. A 
4p16.3 predisposing haplotype (cis-modifier) has been proposed to underlie the 
expansion of high normal length HTT CAG repeats into the disease range[66]. 
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However, this haplotype was not associated with the length of the expanded CAG 
repeat[50] or with its intergenerational instability[67].  
Transgenic and knock-in mouse models of HD recapitulate many aspects of 
intergenerational CAG repeat instability seen in patients[78,81,88,89,91], notably: 
CAG repeat length-dependent instability at similar high frequency (>65%) for long 
alleles (>~100 CAGs)[78] as well as paternal expansion and maternal contraction 
biases[78,88,89]. Offspring sex was also found to contribute to instability in HTT exon 
1 (R6/1) transgenic mice[89]. No obvious role of parental age was discernible in knock-
in models[78]. Cis-modifiers of intergenerational instability were suggested based on 
differential instability in HTT exon 1 transgenic (R6) models with similar CAG repeat 
sizes but distinct transgene insertion sites[81]. DNA repair genes Msh2, Msh3, Msh6 
and Neil1 have been identified as trans-acting modifiers of intergenerational repeat 
instability[90,91,96], and a comparison of HttQ111 knock-in lines on different genetic 
backgrounds indicated the presence of trans-factors that drive strain-specific 
intergenerational instability[91]. 
Here, we have taken advantage of two large breeding datasets comprising 
thousands of transmissions from allelic series of Htt CAG knock-in mice that differ in 
CAG length, genetic background and the presence of a cis-element – a neomycin 
resistance cassette (neo) – upstream of the CAG repeat, to perform a comprehensive 
assessment of the factors that drive intergenerational instability of expanded CAG 
repeat at the mouse Htt locus. These analyses confirm major modifiers of instability, 
distinguish more subtle effects and provide novel insight into potential trans and cis-
mediated effects.   
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3.2. Methods 
3.2.1. Mouse lines  
Breeding data were obtained from The Jackson Laboratory (JAX) for the 
following lines of Htt (formerly Hdh) CAG knock-in mice on a C57BL6/J (B6J) 
background: HttQ20, HttQ50, HttQ80, HttQ92, HttQ111, HttQ140 and HttQ175. The HttQ20, HttQ50, 
HttQ80, HttQ92 and HttQ111 lines were originally derived in the MacDonald 
laboratory[77,78], with HttQ80 being a derivative of the original HttQ92 line obtained by 
selective breeding to smaller CAG repeats. The HttQ140 line was originally derived in 
the Zeitlin laboratory[79], with HttQ175 being a derivative of HttQ140, obtained by 
selective breeding to obtain longer CAG repeats[80]. HttQ20, HttQ50, HttQ80, HttQ92 and 
HttQ111 lines represented in the JAX dataset do not contain the upstream neo cassette 
used in targeting these alleles, however, the HttQ140 and HttQ175 lines retain a neo 
cassette (Figure S8). Together, these lines form part of an “allelic series” of Htt CAG 
knock-in mice for analyses of repeat length-dependent phenotypes[82,113]. 
Subsequent excision of the neo cassette using Cre-mediated recombination resulted 
in a new line of B6J HttQ175neo- mice (B6.129S1-Htt<tm1.1Mfc>/190ChdiJ). Here, for 
simplicity we refer to the HttQ175neo+ mice that form part of the allelic series simply as 
HttQ175, unless we specifically need to distinguish them from their neo- counterpart, in 
which case we refer to the lines as HttQ175neo+ and HttQ175neo-.  
Separately, in-house (CHGR) breeding data were obtained for the HttQ111 line 
on six background strains: CD1, B6J, C57BL/6NCrl (B6N), 129S2/SvPasCrlf (129), 
FVB/NCrl (FVB) and DBA/2J (DBA); as well as for HttQ80 and HttQ92 on CD1 and B6J 
backgrounds[78,91,102]. Data from CD1 or B6J lines (HttQ80, HttQ92, and HttQ111) were 
combined to provide a broad CAG repeat range for each of these background strains. 
None of the lines used for comparisons of instability across different genetic 
backgrounds had a neo cassette. We also analyzed breeding data from CD1.HttQ111 
mice that included an upstream neo cassette[114], which we compared against the 
set of CD1 mice that were missing the neo cassette. In this comparison, we refer to 
these mice as CD1neo+ and CD1neo- respectively. 
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3.2.2. Mouse breeding, husbandry and genotyping 
This study was carried out in strict accordance with the recommendations in the 
Guide for the Care and Use of Laboratory Animals, NRC (2010). All animal procedures 
were carried out to minimize pain and discomfort, under approved IACUC protocols of 
the Massachusetts General Hospital or The Jackson Laboratory. 
Data collected from JAX-maintained Htt CAG knock-in lines followed breeding 
and husbandry conditions described in [113], with genotyping and CAG length 
determination performed in tail DNA at weaning by Laragen Inc. CHGR breeding was 
performed as described in previous work[102,104], and genotyping and CAG length 
determination were performed in tail DNA at weaning as previously described[81,104].  
3.2.3. Intergenerational transmission data 
Both JAX and CHGR breeding data records were quality controlled to eliminate 
entries with obvious and systematic errors (e.g. typographical), or from crosses with 
inconclusive assignment of parental CAG repeat length (e.g. crosses between two 
heterozygous parents and harem breedings). In CHGR’s strain-specific data, only 
mice that were at least sixth-generation backcross progeny (F6, >98% congenic) were 
included, except for B6J.HttQ111, where speed congenics were utilized to generate the 
line[97] and generations F4 (~95% congenic) and after were included. 
Following quality control, the JAX dataset comprised 44,378 pups from crosses 
between a heterozygous knock-in and a wild-type parent. Of these, 22,063 pups 
carried a mutant allele, allowing us to determine CAG repeat length change upon 
transmission. In the JAX dataset, accurate parental age at which the pups were born 
could not be determined. After quality control, the CHGR dataset comprised 1,981 
pups carrying a mutant allele from crosses between heterozygous knock-in sires and 
wild-type dams. In these data we were able to assign parental age at the time of birth 
of the pups unambiguously. 
Repeat length change was determined by subtracting the CAG repeat length in 
the heterozygous knock-in progeny from the CAG repeat length in the respective 
heterozygous knock-in parent. It should be noted that for both the JAX and CHGR 
data, breeding records were accumulated over periods of months/years, and that 
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parent and progeny genotyping were performed at separate times. While standardized 
CAG repeat genotyping assays are used in both cases, there may be some small 
degree of error in the determination of repeat length change, however, this is likely to 
have a negligible impact given the large size of the datasets used in this study.  
3.2.4. Frequency modeling 
To control for possible confounding effects of parental CAG size in the 
frequency of unstable transmissions between different strains/lines, we implemented 
a modeling methodology that allowed a pairwise comparison of the rates of 
expansions, contractions and unchanged transmissions between test strains and a 
reference strain. 
This modeling procedure is represented in Appendix. In essence, 1) weighted 
linear regressions for relative frequencies of expansions, contractions and unchanged 
transmissions versus parental CAG size were determined for the reference strain 
using PASW Statistics 18; 2) a modeled dataset was generated through random 
number generation and allocation as expansion, contraction or stable transmission 
based on the frequency intervals of these events (per paternal CAG size) established 
from the weighted linear regression lines; 3) this was repeated 1,000 times, the 
modeled datasets were averaged, and a dataset based on the average values was 
used for comparative and statistical analyses. To validate this methodology, we 
randomly divided the CHGR B6J set into two subsets with comparable number of 
transmissions: reference and test subsets (n=354 and n=353, respectively). Based on 
the reference dataset, we modeled the frequencies for the test subset, and after 
comparison against the observed values we confirmed that the expected frequencies 
of the test dataset could be predicted with this process (Figure S9). We then applied 
this methodology to compare transmission frequencies: 1) in CD1, B6N, 129, DBA and 
FVB strains against B6J (reference strain); and 2) in neo+ versus neo- mice, where 
either CD1neo- or Q175neo+ were the reference strains (Appendix).  
3.2.5. Statistical analyses 
Frequency analyses were performed using Microsoft Excel 2007 and PASW 
Statistics 18 (IBM). 2 tests of independence, unpaired Student’s t-test for mean 
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comparison, Pearson correlation analyses, and z-tests for column proportions were 
carried out using PASW Statistics 18 (IBM) – actual z-scores and p-values were 
determined using Microsoft Excel 2007 or the on-line Z-Score calculator for 2 
population proportions (http://www.socscistatistics.com/tests/ztest/Default2.aspx). To 
determine the effect of strain background on the magnitude of repeat length changes 
mixed effect model analyses were performed using "nlme" packages in R program 
(v3.2.2). Briefly, CAG repeat size changes (expansions or contractions) were modeled 
as a function of paternal CAG and mouse strain as main effects, with random 
intercepts for sire. Kruskal-Wallis one-way analysis of variance and Dunn's post-test 
were performed with GraphPad Prism 6. Bonferroni correction was applied when 
multiple testing was performed (p-value thresholds stated in text/figure legends). 
Weighted regression lines for number of transmissions per CAG size were calculated 
with PASW Statistics 18. 
3.2.6. Data availability 
Datasets can be provided by the authors upon request.   
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3.3. Results 
To gain insight into factors that influence the intergenerational instability of the 
Htt CAG repeat, we first analyzed a very large breeding dataset from JAX comprising 
>44,000 offspring from heterozygous parents of an allelic series of HD knock-in mice 
– HttQ20, HttQ50, HttQ80, HttQ92, HttQ111, HttQ140 and HttQ175 – on a B6J genetic 
background (Table 3). The vast majority of transmissions were from heterozygous 
knock-in sires, with the HttQ80 and HttQ92 lines also harboring transmissions from 
mutant dams.  
 
Table 3 – Heterozygous and wild-type progeny from Htt knock-in lines in the JAX dataset. 
Line 
Paternal transmissions Maternal transmissions 
Total 
Heterozygous 
progeny 
Wild-type 
progeny 
Total 
Heterozygous 
progeny 
Wild-type 
progeny 
N N (%) N (%) N N (%) N (%) 
HttQ20 7189 3595 (50.0) 3594 (50.0) - - - 
HttQ50 1025 511 (49.9) 514 (50.1) - - - 
HttQ80 4992 2465 (49.4) 2527 (50.6) 263 129 (49.0) 134 (51.0) 
HttQ92 5970 2883 (48.3) 3087 (51.7) 412 200 (48.5) 212 (51.5) 
HttQ111 3098 1550 (50.0) 1548 (50.0) - - - 
HttQ140 3109 1558 (50.1) 1551 (49.9) - - - 
HttQ175 18288 9172 (50.2) 9116 (49.8) - - - 
N, number of transmissions. HttQ20, HttQ50, HttQ80, HttQ92, HttQ111: neo-. HttQ140, HttQ175: neo+ 
 
3.3.1. Segregation of Htt CAG knock-in alleles studied follows Mendelian 
ratios and is independent of CAG length  
A 1:1 Mendelian ratio of heterozygous versus wild-type progeny was broadly 
observed among the lines, with the exception of paternal transmissions in HttQ92 where 
a significant difference (two-proportion z-test, p<0.001) of fairly small effect (1.7% 
lower than expected frequency of heterozygotes) was observed. As this effect was 
unique to this line and not seen in lines with larger repeat sizes, overall, these results 
indicate the lack of an obvious effect of the CAG mutation on the transmission of the 
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Htt allele over a large range of repeat lengths among a very high number of 
transmissions.  
3.3.2. Parental sex influences the direction of repeat length changes but 
does not have a major impact on magnitude 
In human HTT mutation carriers, parental sex is a major determinant of 
intergenerational repeat instability[33,55,56,60–64]. We therefore compared 
frequencies of stable and unstable transmissions (expansions and contractions), as 
well as the magnitude of these alterations between paternal and maternal 
transmissions of the HttQ80 and HttQ92 alleles (Table 4 and Table 5).  
Table 4 – Paternal CAG size and transmission information for the different lines in the 
JAX breeding data  
 
Paternal transmissions 
Parent CAG Total Stable  Contractions Expansions 
Line Min. Max. Mean N N (%) N (%) Max. Mean N (%) Max. Mean 
HttQ20 18 18 18 3595  3591 (99.89) 1 (0.03) 1 1 3 (0.08) 1 1 
HttQ50 46 48 46.6 511 460 (90.0) 29 (5.7) 2 1.1 22 (4.3) 1 1.0 
HttQ80 80 86 83.1 2465 921 (37.4) 330 (13.4) 15 1.2 1214 (49.2) 29 1.7 
HttQ92 91 98 95.8 2883 1010 (35.0) 268 (9.3) 12 1.3 1605 (55.7) 50 1.9 
HttQ111 106 121 113.9 1550 300 (19.5) 248 (16.0) 28 2.1 983 (64.5) 14 2.3 
HttQ140 130 150 137.4 1558 232 (14.9) 172 (11.0) 18 2.2 1154 (74.1) 65 3.2 
HttQ175 178 199 188.9 9172 592 (6.5) 927 (10.1) 128 5.1 7653 (83.4) 153 5.2 
N, number. HttQ20, HttQ50, HttQ80, HttQ92, HttQ111: neo-. HttQ140, HttQ175: neo+ 
Table 5 – Maternal CAG size and transmission information for the different lines in JAX’s 
breeding data. 
 
Maternal transmissions 
Parent CAG Total Stable  Contractions Expansions 
Line Min. Max. Mean N N (%) N (%) Max. Mean N (%) Max. Mean 
HttQ80 83 84 83.2 129 59 (45.7) 59 (45.7) 5 1.4 11 (8.5) 3 1.3 
HttQ92 94 98 96.8 200 70 (35.0) 82 (41.0) 5 1.6 48 (24.0) 20 2.2 
N, number. HttQ80, HttQ92: neo-. 
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For both lines, parent-of-origin determined the frequency distribution of repeat 
length changes (HttQ80: 2=130.86, 2 df, p<0.001; HttQ92: 2=200.58, 2 df, p<0.001), 
with paternal transmissions showing a higher occurrence of expansions, and maternal 
transmissions showing a higher occurrence of contractions (two-proportion z-test, 
p<0.01) but no significant differences in the frequencies of stable transmissions 
(Figure 17). 
 
Figure 17 - Frequency of stable transmissions, contractions and expansions in paternal 
and maternal transmissions of the HttQ80 and HttQ92 alleles in the JAX transmission data. 
**p<0.01. 
Larger maximum expansions and contractions were observed in paternal 
transmissions compared to maternal transmissions, probably partly driven by the 
greater total number of paternal transmissions (Table 4; Table 5). However, parental 
sex did not significantly alter the mean magnitude of the changes in HttQ80 mice 
(contractions: unpaired t-test, p=0.235; expansions: unpaired t-test, p=0.312) or the 
mean magnitude of expansions in HttQ92 mice (unpaired t-test, p=0.467), though the 
mean magnitude of contractions was significantly increased in maternal transmissions 
of the HttQ92 line (unpaired t-test, mean difference=0.348 CAGs, p=0.003;Table 4; 
Table 5; Figure S10). The significance of this is unclear in the absence of additional 
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maternal transmission data from longer alleles, but may indicate a differential 
sensitivity to repeat length of the mechanisms that mediate contractions in the male 
and female germline.  
Overall, in Htt CAG knock-in mice, parent-of-origin mainly influences the 
relative frequencies of expansions and contractions, with a minor impact on the 
magnitude of repeat contractions. 
 
3.3.3. Offspring sex does not influence intergenerational instability in Htt 
CAG knock-in mice  
Previously, effects of offspring sex on intergenerational CAG repeat instability 
were identified in human HTT mutation carriers and R6/1 mouse models of the 
disorder[60,89]. We took advantage of this large breeding dataset to determine 
whether this effect might be recapitulated in transmissions from Htt CAG knock-in 
mice. We examined the frequency and magnitude of repeat length changes inherited 
by male and female progeny in the expanded Htt CAG knock-in lines with available 
data, analyzing paternal and maternal transmissions separately (Table S5).  
For all lines, both in paternal and maternal transmissions, offspring sex did not 
significantly influence either the relative frequencies of contractions, expansions or 
stable alleles (2, Table S6, Figure S11), or the magnitude of expansions or 
contractions (unpaired t-tests, p>0.05, Figure S12). Thus, offspring sex is not a major 
determinant of intergenerational instability in this allelic series of HD knock-in mouse 
models. 
 
3.3.4. Distinct effects of paternal CAG repeat length on the frequency and 
magnitude of changes 
Intergenerational repeat instability is strongly determined by parental CAG 
repeat length in HTT mutation carriers[56,60,63,64,115]. The wide range of CAG 
repeat lengths afforded by the Htt knock-in allelic series allowed us to perform a 
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comprehensive analysis of the effect of parental CAG repeat length on various 
measures of intergenerational repeat instability.  
Given the parent-of-origin effects described above, the influence of parental 
CAG size on repeat transmissions was assessed in paternal transmissions only – 
which constitute the majority of the breeding data available and encompass the widest 
range of allele sizes (Table 4). The HttQ20 line showed ~99.9% stable transmissions. 
The high stability of this normal CAG length allele is to be expected, with the very rare 
repeat length changes consistent with occasional unstable normal alleles in 
humans[67]. Note that HttQ20 was not included in subsequent analyses due to the 
extremely low number of unstable events. 
Frequency distributions of expansions, contractions and unchanged alleles for 
the expanded Htt CAG alleles are shown in Figure 18. In HttQ50 repeat length was 
unchanged in the vast majority of transmissions (90%), while the longer Htt alleles 
showed considerable levels of instability. Mouse line significantly predicted the 
frequency distribution of repeat length change (2=3774.23, 10 df, p<0.001) and 
proportion comparisons revealed that longer repeat lines had significantly higher 
expansion frequencies and significantly lower frequencies of unchanged alleles when 
compared to lines of shorter repeat length (two-proportion z-tests, p<0.003 – 
Bonferroni corrected; Figure 18B). For contractions, significant differences between 
some of the lines were observed but they did not follow any continuous CAG length 
dependence. To better understand these trends, we determined frequencies of 
expansions, contractions and unchanged alleles among the more unstable HttQ80, 
HttQ92, HttQ111, HttQ140 and HttQ175 lines, taking parental CAG size as a continuous 
variable and weighting trend lines by the number of transmissions for each CAG length 
(Figure S13). This confirmed that expansion frequency is positively correlated with 
CAG repeat length (slope=0.298; R2=0.728), that the frequency of unchanged alleles 
is negatively correlated with CAG repeat length (slope=-0.280; R2=0.809), and 
highlights a clearer picture of a fairly constant (~10%-12%) contraction frequency 
throughout the broad CAG range being studied (slope=-0.018 R2=0.029). 
  
73 
 
 
Figure 18 - Relative frequency and significant differences of stable and unstable paternal 
transmissions in JAX’s dataset. (A) Breakdown of transmission frequency by expansions, 
contractions and stable transmissions. (B) Significant differences (p<0.003 threshold after Bonferroni 
correction) between proportions of the different lines are highlighted for expansions (right), contractions 
(center) and stable transmissions (left) 
We also analyzed the effect of CAG repeat length on the magnitude of 
expansions and contractions. The large number of transmissions available for analysis 
allowed us to capture a wide distribution of CAG changes across the different lines 
(Table 4, Figure 19, Figure 20), undetected in previous analyses of intergenerational 
instability in mouse models[78,91]. For most lines, very large changes (>20 CAGs) 
were observed, albeit at low frequencies, with the largest repeat size change being an 
expansion of 153 CAGs in HttQ175 (Figure S12). Mouse line was found to significantly 
predict the magnitude of both expansions and contractions (Kruskal-Wallis test, 
p<0.0001). Dunn's multiple comparisons test showed significantly higher mean 
expansions and contractions for most lines when compared to others with lower repeat 
lengths (p<0.05, multiplicity adjusted [116]; Figure 20B). Expansions appeared more 
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sensitive to CAG repeat length, with expansions up to 20 CAGs apparent by ~80 CAGs 
(HttQ80, Figure S12) and contractions of the same magnitude only apparent by ~106 
CAGs (HttQ111, Figure S12). Notably, in HttQ50 transmissions, repeat length changes 
varied only from -2 to +1 CAGs, demonstrating the relatively high stability of this repeat 
size in these mice.  
 
Figure 19 - Relative frequency of CAG size changes within specific ranges across all 
lines. Stable transmissions (blue), contractions (green), expansions (red). 
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Figure 20 - Magnitude of change and significant differences in mean expansion and 
contraction among paternal transmissions in the JAX transmission data. (A) Boxplot 
representation of CAG change in paternal transmissions for each line (boxes: interquartile range of 
transmissions; whiskers: 1-99 percentile of transmissions; red diamonds: average expansion size; 
green diamonds: average contraction size). 
 
Overall, while CAG repeat length in transmitting fathers is a major driver of 
intergenerational CAG instability, our analyses have distinguished CAG length-
dependent effects on the frequency and magnitude of expansion and contraction 
events. Thus, while longer CAG lengths are associated with larger expansions and 
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contractions, they do not impact the likelihood of contraction events, but only increase 
the frequency of expansions at the expense of unchanged alleles.  
3.3.5. Paternal age has a minor impact on the magnitude of CAG repeat 
expansions 
In an effort to probe for additional factors that might contribute to 
intergenerational CAG instability we analyzed a second dataset of intergenerational 
repeat length transmissions generated from CHGR’s breeding of Htt CAG knock-in 
mice. This dataset is composed of ~1800 paternal transmissions of heterozygous Htt 
knock-in alleles, on six different genetic backgrounds – 129, CD1, FVB, DBA, B6N, 
and B6J – spanning a range of 81 to 153 CAGs (Table 6, Figure S14B). 
 
Table 6 – Paternal age at offspring birth, CAG size and transmission information for the 
different lines in CHGR’s breeding data. 
BG 
Parent Transmissions 
N 
Age at offspring 
birth (weeks) 
CAG 
N 
Stable  Contractions Expansions 
Min. Max. Mean Min. Max. Mean N (%) N (%) Max. Mean N (%) Max. Mean 
129 32 9 40 21.4 105 114 109.7 213 72 (33.8) 63 (29.6) 8 1.6 78 (36.6) 9 1.7 
CD1 59 7 42 18.6 81 139 105.7 439 116 (26.4) 51 (11.6) 8 1.7 272 (62.0) 12 1.8 
FVB 24 9 41 18.9 111 147 132.0 180 32 (17.8) 25 (13.9) 5 2.2 123 (68.3) 9 2.7 
DBA 12 9 38 17.3 115 129 123.0 64 8 (12.5) 8 (12.5) 4 2.8 48 (75.0) 6 2.4 
B6N 38 9 74 26.1 109 138 119.2 226 40 (17.7) 51 (22.6) 11 1.8 135 (59.7) 6 2.3 
B6J 55 8 62 28.0 83 153 128.3 707 73 (10.3) 74 (10.5) 19 2.9 560 (79.2) 21 3.5 
BG, background; N, number. All strains: neo- 
This dataset included paternal age at offspring birth, therefore allowing us to 
evaluate its potential contribution to intergenerational instability. Given that the B6J 
strain had both the largest number of transmissions and a broad paternal age range, 
we analyzed the effect of paternal age on a subset of B6J transmissions (parental age: 
8 to 62 weeks; HttQ111, CAG range: 113-153; N=690). In this dataset and select repeat 
length range there was no relationship between paternal age at offspring birth and 
paternal CAG (Figure S15). Therefore, we used this dataset to determine whether 
paternal age influenced intergenerational instability.  
Paternal age did not significantly alter the frequency of expansions, 
contractions or unchanged alleles (Figure S16), showed no correlation with the 
magnitude of repeat contractions (Pearson correlation=0.031, p=0.8), but showed a 
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modest though statistically significant correlation with the magnitude of the expansions 
(Pearson correlation=0.253, p<0.001; Figure 21).  
 
Figure 21 - CAG expansions by paternal age at offspring birth (weeks) in CHGR’s B6J.HttQ111. 
Bubble size is proportional to the total number of observed events (expansions), black diamonds 
represent average expansion per discrete age (N=690). 
 
3.3.6. Multiple background strains alter intergenerational CAG repeat 
instability. 
We previously analyzed, using a much smaller transmission dataset, strain-
specific differences in paternal intergenerational instability of the CAG repeat in Htt 
CAG knock-in mice using three inbred mouse strains (B6N, FVB, 129) and found a 
significantly greater frequency of intergenerational changes in repeat length 
(combined expansions and contractions) in B6N mice compared to 129 mice [91]. 
Here, afforded by a greatly increased number of transmissions and an expanded set 
of mouse strains, we aimed to investigate further potential effects of genetic 
background on intergenerational instability upon paternal CAG repeat transmission.  
A comparison of the frequencies of expansions, contractions and stable 
transmissions across the six strains revealed clear differences in instability (Table 6, 
Figure S14A), however, the different paternal CAG repeat length distributions for each 
of the different strains suggest that CAG repeat length (Table 6, Figure S14B) may, in 
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part, contribute to the differences in instability between the strains. To control for this, 
we modeled the frequencies of expansions, contractions and unchanged alleles as a 
function of CAG repeat length in the B6J strain that has the broadest range of parental 
CAGs as well as the most transmissions. We then compared the actual transmission 
frequencies observed in each of the other five strains to transmission frequencies 
predicted from the B6J model (Appendix and Methods). These results are represented 
in Figure 22 as pairwise comparisons between the observed (e.g. 129) and the 
expected transmission distributions determined by B6J modeling (e.g. m129). 
 
Figure 22 - Comparison of expansions, contractions and stable transmissions 
frequencies in various strain backgrounds with B6J-modeled distributions. (A) Observed and 
expected (m) frequencies for each strain. (B) Percent difference between observed and expected 
frequencies for expansions, contractions and unchanged transmissions. **p<0.01, *p<0.05 
The data show that frequencies of expansions, contractions and unchanged 
alleles in the DBA strain do not differ significantly from those in B6J. In contrast, 129 
is the most dissimilar to B6J, with 35% fewer expansions (two-proportion z-test, 
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p<0.01) and 17-18% more contractions and stable transmissions (two-proportion z-
tests, p<0.01). CD1 and FVB both show significantly reduced frequencies of 
expansions (two-proportion z-test; CD1, p<0.05; FVB, p<0.01) and significantly 
increased frequencies of unchanged alleles (two-proportion z-test, p<0.05) compared 
to B6J. Interestingly, despite being the most highly related to B6J, B6N exhibited a 
16.1% decrease in expansion frequency (two-proportion z-test, p<0.01) and an 11.2% 
increase in the frequency of contractions (two-proportion z-test, p<0.01).  
It is notable that the results obtained based on modeling in B6J as a means to 
overcome paternal repeat length differences are mostly consistent with the initially 
observed differences in instability across the strains (Figure S14A), suggesting that, 
at least within the range of CAG repeats encompassed by these strains, genetic 
background, rather than CAG repeat length, is the more significant determinant of 
repeat instability, with distinct strains differentially modifying the frequencies of 
expansions, contractions and stable alleles.  
The effect of background strain on the magnitude of repeat length change was 
also assessed using B6J as a reference and controlling for CAG size effects through 
mixed model analyses. Strain background did not influence the size of the contractions 
(data not shown). However, analysis of the strain effect on magnitude of expansions 
revealed significantly smaller changes compared to B6J in all strains except DBA, with 
129 and CD1 being the most dissimilar to B6J and having the greatest “protective” 
effect (Table 7). 
Table 7 – Effect of background strain on the magnitude of CAG expansions. 
Strain Intercept P-value 
B6J 1.09 NA 
B6N 0.27 0.001 
129 -0.17 <0.001 
CD1 -0.09 <0.0001 
DBA 0.33 0.054 
FVB 0.31 0.005 
CAG changes in offspring were modeled, as a function of paternal CAG repeat length and strain 
background, in a mixed effect model context with random intercept. Paternal CAG repeat significantly 
explained variance in size of CAG expansions, with an estimated effect size of 0.017 increase in 
expansion magnitude per paternal CAG repeat unit increment (p=0.0182). P-values represent 
significance when compared to the reference strain B6J. 
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3.3.7. The presence of a neo cassette upstream of Htt reduces the CAG 
expansion frequency 
Previous data have indicated a role for cis-acting modifiers of CAG repeat 
instability in HD transgenic mice[81,117]. To explore the role of cis elements that might 
influence CAG repeat instability at the Htt locus, we have taken advantage of Htt 
knock-in lines that differ by the presence or absence of an upstream neomycin (neo) 
resistance cassette (Figure S8, Table S7). We compared intergenerational instability 
in paternal transmissions from the CD1 Htt CAG knock-in mice described above, which 
do not contain a neo cassette (CD1neo-), with intergenerational instability in paternal 
transmissions from CD1 Htt CAG knock-in mice harboring an upstream neo cassette 
(CD1neo+)[77] (Table S7).  
Direct comparison between these two strains indicated the absence of any 
significant differences in frequencies of expansions, contractions or stable alleles 
(Figure 23A, two leftmost bars). However, the significantly higher mean paternal CAG 
size (unpaired t-test, p<0.001) and range of CAG repeats in the CD1neo+ mice (Figure 
7B, two leftmost bars) suggested that we may be underestimating instability in the 
CD1neo- mice relative to that in the CD1neo+ mice due to repeat size effects. We dealt 
with the CAG size discrepancies using two approaches (Figure 23A and B): 1) 
Adjusting the CD1neo- dataset to only include transmissions from a paternal CAG range 
equivalent to the CD1neo+ set (adjCD1neo-); 2) Modeling frequencies of events in the 
CD1neo+ mice based on data from the CD1neo- mice (mCD1neo+) – as previously 
performed for the strain background analyses; see Methods and Appendix for details. 
When controlling for paternal CAG size by either of these two approaches we find that 
CD1neo+ sires are approximately 10% less prone to expansions, with nominal 
significance (two-proportion z-tests, p<0.05) that did not withstand multiple test 
correction (Bonferroni significance threshold set at p=0.0167), with minor and not 
statistically significant differences in frequencies of contractions or stable 
transmissions (Figure 23A). 
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Figure 23 – Effect of an upstream neo cassette on the frequency of stable and unstable 
transmissions. (A) Frequency of changes in CD1 background lines either containing a neo cassette 
upstream of the Htt gene (neo+), or not (neo-), as well as adjusted and modeled corrections for parental 
CAG size effects (see Table S7). (B) Parental CAG range for the different CD1 lines, as well as adjusted 
and modeled subsets. (C) Frequency of changes in HttQ175 B6J background lines containing (neo+) or 
not (neo-) a neo cassette upstream of the repeat, as well as adjusted and modeled corrections for 
parental CAG size effects (see Table S7). (D) Parental CAG range for the different HttQ175 (B6J) lines, 
as well as adjusted and modeled subsets. **p<0.01, *p<0.0167 (Bonferroni corrected). 
Differences in the magnitude of changes were evaluated by comparing mean 
changes between the CD1neo+ and the adjCD1neo- set. No significant differences were 
observed in either mean expansion size (CD1neo+: 2.1 CAGs; adjCD1neo-: 2.1 CAGs; 
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unpaired t-test, p=0.961) or contraction size (CD1neo+: 1.6 CAGs; adjCD1neo-: 1.4 CAGs; 
unpaired t-test, p=0.610). 
As these results indicated cis effects on the frequency of unstable 
transmissions we also investigated a distinct breeding set from the JAX that comprised 
transmissions from HttQ175neo- parents on a B6J background (Table S7). We compared 
the instability in paternal transmissions of this allele with those from the HttQ175neo+ 
allele (B6J), which formed part of the allelic series described above. 
Direct comparison between the two lines revealed significantly lower expansion 
frequency in HttQ175neo+ mice (two-proportion z-test, p<0.01; Figure 23C), despite a 
higher mean paternal CAG repeat size (unpaired t-test, p<0.001; Figure 23D), as well 
as a significantly increased contraction frequency (two-proportion z-test, p<0.0167), 
and a small non-significant increase in the frequency of stable transmissions (two-
proportion z-test, p=0.057 – significance threshold set at p=0.0167).  
To control for CAG repeat length we employed the two approaches described 
above: 1) Using a subset of the HttQ175neo+ mice with parental CAGs in the same range 
as those in the HttQ175neo- mice (adjHttQ175neo+; Table S7) and 2) Modeling frequencies 
of events in the HttQ175neo- line based on data from the HttQ175neo+ mice (mHttQ175neo-; see 
Methods and Appendix). When controlling for CAG size using the adjustment method, 
we found a significantly reduced expansion frequency in HttQ175neo+ (two-proportion z-
test, p<0.01), while the effect was only nominally significant when adjusting through 
the modeling methodology (two-proportion z-test, p=0.03 – Bonferroni corrected 
significance threshold p=0.0167), likely due to the reduced sample size enforced by 
this methodology (Figure 23D and Table S7). We did not find any significant 
differences in the mean magnitude of expansions (HttQ175neo-: 5.7 CAGs, adjHttQ175neo+: 
5.2 CAGs; unpaired t-test, p=0.565) or contractions (HttQ175neo-: 9.07 CAGs, 
adjHttQ175neo+: 5.42 CAGs; unpaired t-test, p=0.112) in a comparison between HttQ175neo- 
and the paternal CAG-adjusted HttQ175neo- mice. 
Taken together these analyses indicate that the existence of a neo cassette 
upstream of the repeat seems to be a protective factor, reducing the frequency of 
expansions (by ~6.5-11.5%), in two different HD knock-in mouse models, but having 
no discernible effects on the magnitude of the repeat length changes.  
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3.4. Discussion  
The length of the expanded CAG repeat plays a critical role in HD, influencing 
both penetrance and age of onset[19,33,35,52,55,61,111]. Underlying the variation in 
inherited CAG repeat length between individuals are high rates (~70-80%) of 
intergenerational instability[33,56,59,60,69]. Here, we have analyzed thousands of 
intergenerational transmissions across multiple lines of Htt CAG knock-in mice, in 
order to gain further insight into factors that may influence instability.  
The availability of an allelic series of mice differing by CAG repeat tract length 
provided the opportunity to investigate CAG-dependent aspects of repeat 
transmissions. We first determined whether there was any evidence for segregation 
distortion of the Htt allele. This has previously been suggested for a number of 
CAG/CTG repeat diseases, although the data in support of this phenomenon are 
conflicting[118–121]. The majority of the allelic series lines showed the expected 1:1 
Mendelian ratio of heterozygous and wild-type mice in transmissions from 
heterozygous parents. The only exception occurred in HttQ92 paternal transmissions 
which showed a relatively small decrease in the number of heterozygous progeny 
(~1.7% less than expected). Given that this was not seen in lines with shorter or longer 
repeat lengths this minor deviation from the expected 1:1 ratio is likely a stochastic 
effect, clearly not driven by CAG repeat length. Overall, our transmission analyses of 
a broad range of expanded CAG repeats provide evidence for no segregation 
distortion of the mutant Htt allele in mouse, supporting data derived from single sperm 
genotyping in HD individuals[122], and suggesting that locus-specific effects rather 
than repeat length, primarily drive any potential segregation distortion seen in other 
diseases[118–121].  
For the lines with both paternal and maternal transmissions (HttQ80 and HttQ92, 
B6J background), we confirmed previous results in HD patients and in knock-in mice 
on a different (CD1) genetic background[78] showing a strong expansion bias in male 
transmissions. We also confirmed a contraction bias in maternal transmissions 
observed previously in CD1 knock-in mice[78], differing somewhat from maternal 
transmissions in HD patients that show approximately equal expansion and 
contraction frequencies[60,63,64]. Limited studies carried-out to date indicate that 
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repeat expansions in the male germline can occur at multiple stages during 
spermatogenesis[123,124]. Though the male expansion bias may be related to the 
large number of mitotic cell divisions of pre-meiotic spermatogonia, in the present 
study, and in line with previous data in HD patients[60], we found only a minor effect 
of paternal age in determining the magnitude of CAG expansions despite our analyses 
of a large number of transmissions over a broad age range. As increasing paternal 
age is expected to correlate with increased accumulation of repeat expansions in 
continually replicating spermatogonia, the mouse and human data overall do not 
strongly support spermatogonial cell divisions as the major source of CAG expansions, 
consistent with the lack of positive correlation of cell division rate with repeat 
instability[93,125]. Further understanding of the sex- and cell-type-specific processes 
that drive the generation of repeat expansions and contractions would be of 
considerable interest.  
A small effect of offspring sex on intergenerational instability has been 
previously observed in a large Venezuelan HD pedigree, implying a role for 
postzygotic factors that influence instability[60]. Embryo sex also influenced instability 
in the R6/1 transgenic mouse model[89]. Here, analyzing large numbers of 
transmissions, we observed no significant effects of offspring sex on the frequency or 
magnitude of repeat length changes in either paternal or maternal transmissions in 
any of the lines studied. Even though a minor effect of offspring sex may be present 
in humans and transgenic mouse models it is not observable in the knock-in.  
Parental CAG repeat length has been proposed as a major contributor to 
intergenerational repeat instability in patients[56,60,63,64]. Here we have examined 
paternally transmitted CAG repeats over a large range of repeat lengths (18 to ~200) 
and found that CAG repeat length determines the magnitude of both expansions and 
contractions. With the number of transmissions analyzed in this study, we were able 
to detect large (>10-20 CAGs) repeat length changes that are found, typically in 
paternal transmissions in HD patients that push the repeat into the range associated 
with juvenile-onset disease. Notably, however, such repeat length changes are rare in 
the mouse and were not detected in HttQ50 mice harboring CAG repeat lengths typical 
of adult-onset HD in patients. What underlies the apparent stability of the Htt CAG 
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repeat in the mouse compared to that in humans is unclear. This may simply be related 
to the distinct time-spans of gametogenesis in the two species, or alternatively, may 
reflect underlying differences in the mechanisms that drive repeat length changes. 
However, the high frequency of small repeat length changes and the detection of 
larger changes, albeit at low frequency, in mice harboring longer CAG repeats would 
suggest that the mechanisms that generate such changes are conserved in the 
mouse.  
We also found that longer CAG repeat lengths were associated with a higher 
frequency of repeat expansions. Interestingly, this was mirrored by a decrease in the 
frequency of unchanged alleles, with no effect on the frequency of contractions, 
despite the association of repeat length with the magnitude of the contractions. This 
may reflect different mechanisms underlying expansions and contractions. In this 
scenario, mechanism(s) driving expansions are engaged in a repeat length-dependent 
manner; in contrast, mechanism(s) driving contractions are engaged regardless of 
repeat length, but once engaged, longer CAG lengths are more likely to drive larger 
contractions. Previous observations in which paternal transmissions of HttQ111 Msh2 
knockout mice exclusively exhibited contractions, in contrast to the predominant 
expansions in HttQ111 mice wild-type for Msh2 [90], support separate expansion and 
contraction mechanisms that are, respectively, dependent on and independent of 
Msh2. Different mechanisms of intergenerational expansion and contraction of 
CAG/CTG repeats are supported by several additional studies[104,110,126,127].  
Expanding on previous work[91], we analyzed intergenerational changes 
across six genetic backgrounds – 129, CD1, FVB, DBA, B6N and B6J – and in 
expanded datasets that afford the power to distinguish strain-specific effects on both 
the frequency and magnitude of changes as well as on expansions and contractions.  
Overall, B6J and DBA were the most unstable strains, possessing similar 
frequencies and magnitudes of repeat length changes, while 129 was the most stable 
strain, with the low frequency and magnitude of changes in this strain consistent with 
previous data[91]. More specifically, we observed that different strains variably altered 
the relative frequencies of expansions, contractions and stable transmissions (Figure 
22). Strain background also modified the magnitude of the expansions but not the 
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magnitude of the contractions, though this may be in part due to the lower number of 
contraction events. As all of these strains were derived from an initial HttQ111 line, 
generated by targeting in 129 embryonic stem cells[78], all the Htt knock-in alleles are 
on a local 129 haplotype, and any differences in instability can likely be attributed to 
trans-effects, mediated by variation in other genes.  
Previous analyses point to Mlh1 genetic variation underlying differences in Htt 
CAG somatic instability between 129 and B6N strains[102]. Given overlapping roles 
of mismatch repair (MMR) genes in somatic and intergenerational instability in HD 
[90,104] and other repeat disorders[126,128], it seems likely that Mlh1 genetic 
variation underlies the 129 versus B6 (B6N and B6J) differences in intergenerational 
instability. Interestingly, the reduced frequency of expansions in the 129 strain was 
accompanied by an increased contraction frequency, reminiscent of the impact of loss 
of Msh2[90] and further suggesting that genetic variation in 129 might impact the same 
pathway(s). Additional, unbiased genetic analyses would be needed to uncover the 
modifier(s) responsible for the reduced intergenerational instability in 129 mice, as well 
as in other strains. Interestingly, although B6J and B6N are closely related strains, 
B6N showed an increase in the frequency of contractions and a decrease in frequency 
and magnitude of expansions relative to B6J. While these strains do not have any 
coding or obvious regulatory region SNPs in MMR genes (data not shown), the limited 
genetic variation between the two strains may provide an opportunity to uncover, new 
modifiers that shift the balance of repeat length changes from expansions toward 
contractions.  
In addition to genetic background strain effects attributable to trans-acting 
modifiers, we also examined potential cis-effects by comparing intergenerational 
instability in strains with and without a neo cassette upstream of the knock-in repeat. 
The presence of the neo cassette was associated with reduced expansion frequency 
in paternal transmissions, without having an effect on the magnitude. We observed 
this effect independently of paternal CAG size effects, in two different background 
strains (CD1 and B6J) in the context of two knock-in lines (HttQ111 and HttQ175) with 
different sites of neo insertion (Figure S8). 
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Considerable data support a role for cis-acting modifiers of trinucleotide repeat 
instability[117,129,130]. At the human HTT locus itself, an instability-promoting 
haplogroup has been proposed to drive expansion from the high normal range[66], 
however HTT haplotype does not modify the intergenerational instability of expanded 
CAG repeats[50]. Regardless, cis-modifiers of HTT CAG instability in model systems 
may provide insight into underlying mechanisms. Reduced instability in the presence 
of the neo-insertions may be a consequence of chromatin structural changes, and/or 
alteration of Htt transcription levels during germ cell generation. Interestingly, the 
orientation of the neo cassette, in relation to the Htt knock-in allele, is different between 
the HttQ111 and HttQ175 lines (sense and antisense, respectively), and although the neo 
insertion in the HttQ111 allele dramatically reduces its transcription resulting in a 
“hypomorphic” allele[114] the neo insertion in the HttQ175 allele does not have the same 
impact on Htt expression[82]. This suggests that altered transcription may not be the 
major contributor to reduced instability in the neo+ mice, but rather that local sequence 
structure/chromatin configuration may impact CAG instability via other mechanisms. 
While this study was not specifically geared towards providing a comprehensive 
understanding of the molecular mechanisms underlying CAG repeat instability, our 
results provide some general insights that may help to direct future research in this 
area. Our observation that age is not a major determinant of intergenerational 
instability implies a major role for DNA repair processes that are not directly linked to 
DNA replication. We suggest that a minor component of intergenerational instability is 
driven by processes directly linked to DNA replication, where MMR proteins may act 
at the level of post-replicative MMR, or may play a direct role at the replication 
fork[127,131]. We also provide further evidence that mechanisms of intergenerational 
expansion and contraction can be distinguished, perhaps in part reflecting different 
cell-types in which these events may predominate. Thus, further efforts to understand 
mechanisms underlying repeat contraction are warranted to provide opportunities for 
therapeutic strategies aimed at reducing repeat length. 
In summary, our comprehensive analyses of intergenerational transmissions of 
Htt CAG repeats in HD knock-in mice confirms parent-of-origin and CAG repeat length 
as the major modifiers of intergenerational instability, as in HD patients. The large 
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datasets have also allowed us for the first time to discern more subtle effects on 
instability, e.g. distinguishing CAG-dependent effects on frequency and magnitude of 
expansions and contractions, and to identify large repeat size jumps seen in HD 
patients, the latter suggesting that fundamental mechanisms of CAG instability are 
shared between human and mouse. Evidence for both cis- and trans-modifiers of 
instability provides a starting point to uncover the underlying modifying factors in the 
mouse, which will provide further insight into intergenerational instability in patients. 
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3.5. Supplementary material 
3.5.1. Supplementary figures 
 
Figure S8 – Schematic representation of the Htt locus representing the different lines 
used in this study as well as the relative location and direction of the neo cassette and other 
locus elements. 
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Figure S9 – Validation of the frequency modeling methodology for comparison of 
intergenerational instability across different datasets. Left bar represents the frequencies observed 
within 50% of the B6J dataset (n=353), while the right bar represents the same dataset with frequencies 
modeled based on the remaining 50% (n=354) which was used as the reference dataset. No significant 
differences were observed. 
 
Figure S10 – Magnitude of changes in paternal and maternal transmissions (HttQ80 and 
HttQ92) in JAX’s transmission data. Representation of CAG change for all maternal and paternal 
transmissions observed (dotted, black), in the HttQ80 and HttQ92 lines, as well as mean expansion 
(diamonds, red) and mean contraction (diamonds, green) values (see also Table 4; Table 5). **p<0.01  
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Figure S11 – Relative frequency of stable and unstable transmissions by offspring sex 
in the JAX Htt CAG knock-in dataset. Breakdown of transmission frequency by expansions (red), 
contractions (green) and stable transmissions (blue) separated by offspring sex among paternal (A) and 
maternal (B) transmissions. 
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Figure S12 – Magnitude of changes segregated by offspring sex in paternal and maternal 
transmissions in JAX’s transmission data. Representation of CAG changes for all paternal (A) and 
maternal (B) transmissions observed (dotted, black) in the available lines, as well as mean expansions 
(diamonds, red) and mean contractions (diamonds, green). 
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Figure S13 – Relative frequency of stable and unstable (expansions, contractions) 
transmissions by paternal CAG size in JAX’s dataset. Breakdown of transmission frequency by 
expansions, contractions and stable transmissions using paternal CAG size as a continuous variable. 
Trend lines weighed by the total number of observed transmissions for each parental CAG length are 
represented as dotted lines. Bubble size is proportional to the total number of observed events. Events 
with null frequency (N=0) are considered for trend line weighing but are not depicted as bubbles. 
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Figure S14 – Frequency of changes and paternal CAG sizes across the six genetic 
backgrounds. (A) Frequency of expansions, contractions and stable transmissions across different 
strains in the CHGR breeding dataset (B) Parental CAG range among the six strains (boxes encompass 
50% of total transmissions, whiskers represent minimum to maximum size). 
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Figure S15 - Distribution of parental CAG repeat size across paternal age at birth in the 
B6J.HttQ111 mice (113-153 CAGs; N=690 transmissions) in CHGR’s breeding dataset. 
 
Figure S16 – Frequency of changes by paternal age at offspring birth (B6J background, 
CHGR dataset). Trend lines weighed by the total number of observed transmissions for each parental 
age are represented as dotted lines. Bubble size is proportional to the total number of observed events. 
Events with null frequency (N=0) are considered for trend line weighing but are not depicted as bubbles. 
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3.5.2. Supplementary tables 
Table S5 – Paternal and maternal transmission data for the different lines segregated by 
offspring sex in JAX's breeding data. 
 
Table S6 – 2 and p-values for offspring sex effect on the relative frequencies of 
contractions, expansions and stable alleles in the JAX Htt CAG knock-in dataset. 
 
Table S7 – Characteristics of paternal CAG intervals and transmission frequency and 
magnitude in the neo+, neo- and adjusted datasets. 
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4. Characterization and comparison of somatic 
repeat instability in HttQ175neo- and HttQ175neo+ 
HD mouse models
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4.1. Introduction 
Somatic instability of the repeat is a prevalent feature in mouse models of 
HD[78,81,97]. Both neuronal and non-neuronal tissues are affected by CAG repeat 
size changes, with liver and striatum showing the most dramatic changes in HttQ111, 
R6/1 and R6/2 models[78,97,102]. Instability in HttQ175 tissues has been observed, but 
has of yet not been thoroughly characterized.  
Overall, a large amount of evidence regarding trans-acting modifiers of somatic 
instability has been amassed using the aforementioned HttQ111 mice as well as R6/1 
models[92,102–104,132]. Genetic background of HttQ111 mice was shown to influence 
somatic instability, with B6 and FVB strains showing larger changes in repeat size than 
the 129 strain. Through linkage mapping the likely culprit of differences in instability in 
the striatum was identified as Mlh1, and validation of this fact was performed through 
the generation of HttQ111.Mlh1-/- (knock-out) mice, which show a high ablation of 
expansions in striatum and liver. This same strategy crossing HD models with knock-
out mice for other MMR genes such as Msh2, Msh3, Mlh1, Mlh3, and 
Neil1[90,92,102,104], has been prolific in the identification of somatic instability trans-
modifiers. In the case of Mlh1 and Msh3, even naturally occurring SNPs have been 
found to probably be the underlying cause of instability differences amongst distinct 
strains[102,103]. 
While mounting evidence has been found for trans modifiers of somatic 
instability, little is known regarding cis and short-range modulators in mouse models, 
the most substantial indicators of cis-modifiers relate to early reports of differential 
instability amongst R6 models, where the expanded repeat showed very distinct 
profiles of repeat size changes in numerous tissues depending only on a different 
insertion location and genetic context[81]. 
In the previous chapter we described a potential role for a specific cis-element, 
a neomycin resistance cassette upstream of the repeat, as a modulator of 
intergenerational instability in HttQ175 (B6J) and HttQ111 (CD1) models, namely through 
a visible effect in the reduction of expansion frequency.  
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In this work we set out to characterize somatic instability in different tissues of 
HttQ175neo- and HttQ175neo+ models, assessing differences in tissue instability within each 
of the lines and searching for possible instability modulation effects of the neo 
sequence upstream of the repeat. 
4.2. Animals and methods 
4.2.1. Animals and tissues 
HttQ175neo- and HttQ175neo+ mice (8 for each line, 4 male, 4 female) were acquired 
from the The Jackson Laboratory and were sacrificed and perfused with 
paraformaldehyde for tissue fixation at 7-weeks-old, as previous results from the lab 
showed that older mice with typical repeat sizes from this line show very high levels of 
instability hard to quantify through the methodology here applied, and should still be 
appropriate toward finding possible differences.  
Several tissues were collected and subsequently frozen. Part of seven of the 
collected tissues – tail, heart, spleen, liver, cerebellum, cortex and striatum – was 
chipped from the frozen samples and utilized for DNA extraction.  
4.2.2. DNA extraction 
DNA was extracted using the 5 PRIME (Fisher Scientific) Manual ArchivePure 
DNA Purification methodology. Tissues were incubated overnight at 50 °C, in 300µL 
of Cell Lysis Solution (5 PRIME) and 5µg of Proteinase K. The “broken-down” tissue 
solutions were subsequently incubated with RNAse A for 1h at 37 °C. Samples were 
then moved to room temperature (RT) and 100µL of Protein Precipitation Solution (5 
PRIME) was added, followed by vortex homogenization, and samples were 
subsequently cooled on ice for 20 minutes. At RT, samples were centrifuged for 3 
minutes at 13000 rpm, supernatants were transferred to new tubes and pellets were 
discarded. 300µL of molecular biology grade isopropanol (Fisher Scientific) were 
added to the new tubes for DNA precipitation and manual homogenization was 
performed by inversion (15 to 20 times) or until precipitated DNA was visible. Samples 
were centrifuged once more at 13000 rpm for 3 min. Supernatants were then 
discarded and DNA pellets were washed with 300µL of a 70% ethanol solution by 
manual inversion. Samples were subjected to a final centrifugation at 13000 rpm for 1 
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minute and ethanol supernatants were carefully removed to avoid disturbing DNA 
pellets. Samples were left to air dry for ~20 minutes and were then solubilized in TE 
buffer. 
DNA concentration was determined through spectrophotometry using a 
Nanodrop 1000 and afterwards diluted to 40ng/µL for downstream use. 
4.2.3. Determination of somatic instability 
Fragment analysis was performed to evaluate instability in the tissues of 
interest, starting with a polymerase chain reaction (PCR) of the sequence containing 
the expanded repeat. PCRs were performed using the Taq PCR Core Kit (Qiagen) 
where each reaction contained 1x PCR buffer (Qiagen), 20% Q-solution (Qiagen), 16 
nmol of HU3 (5' GGCGGCTGAGGAAGCTGAGGA 3') and labelled CAG1 (5' 6-FAM-
ATGAAGGCCTTCGAGTCCCTCAAGTCCTTC 3') primers – well characterized and 
specific to the humanized repeat containing allele –, 4 nmol of dNTPs and 0.5 units of 
Taq in a final volume of 20µL. Cycling conditions were as follows, 95 °C 5min, 30 
cycles of 94 °C 30sec ,65 °C 30 sec, 72°C 90sec, followed by 10 min at 72 °C. 
Products were then subjected to capillary electrophoresis in an ABI3730 (Applied 
Biosystems) sequencer. Electropherograms were subsequently analyzed with 
GeneMapper Software v5.0 (Applied Biosystems) undergoing rigorous quality control 
and validation.  
Somatic instability was determined using a method previously described[93]. In 
short: the PCR reaction generates different products  of multiple sizes that when 
analyzed in GeneMapper appear as a cluster of peaks differing from each other by 
one CAG repeat unit, and peak height is proportional to the number of alleles 
containing a specific repeat size that are amplified from the mixture of genomic DNA 
of different repeat lengths; the peak containing the highest signal is considered the 
“main allele”; alleles to the right are considered expansions and alleles to the left 
contractions; heights for all alleles of interest are extracted and individual peak heights 
are normalized to the sum of all heights; normalized peak heights are then multiplied 
by a factor determined by the change/distance to the main allele (e.g. for an allele 1 
CAG smaller than the main allele this factor is -1, for an allele 2 CAGs larger the factor 
is 2, and so forth); the values stemming from this calculation are then added together 
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generating the instability index. Expansion and contraction indexes can also be 
determined, adding only the peaks to the right or left of the main allele. 
In this study, slight changes to the methodology were applied. Instead of adding 
a relative threshold (e.g. 20% height of the main allele) as described in the original 
method[93], an absolute threshold of 50 for minimum peak height was applied (without 
any relative threshold application, as noise levels here were fairly low and this allowed 
to capture the most amount of expanded alleles), and alternatively to the instability 
index, an absolute instability index – consisting of the sum of the expansion index and 
the absolute value of the contraction index – was calculated. 
 
4.3. Statistical analyses 
Comparisons between tissues’ absolute instability, expansion indexes and 
contraction indexes within the HttQ175neo- and HttQ175neo+ lines were evaluated through 
one-way ANOVA analyses separated in two distinct groups of neuronal and non-
neuronal tissues. The Brown-Forsythe test was utilized to verify homogeneity of 
variances within groups. When variances were significantly different, data 
transformations were applied – in the HttQ175neo- line for absolute instability, expansion 
indexes of non-neuronal tissues, and for contraction indexes of neuronal tissues 
reciprocal transformations (1/x) were performed, while in the HttQ175neo- line a power 
transformation (x2) was applied – allowing variances’ homogenization and applicability 
of the ANOVA. Specific differences between the tissues were evaluated with the post-
hoc Tukey's multiple comparisons test with multiplicity adjusted p-values. Both 
analyses were performed with Graphpad Prism v6.01. 
Differences between the two lines (HttQ175neo- and HttQ175neo+), including 
differences in main allele repeat sizes in heart and cerebellum, as well as 
expansion/contraction indexes and absolute instability in tail, heart, spleen, liver, 
cerebellum, cortex, and striatum were evaluated with unpaired Student’s t-test for 
mean comparison, also using Graphpad Prism v6.01. 
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4.4. Results 
Representative traces for each tissue in the HttQ175neo- and HttQ175neo+ lines are 
shown in Figure 24. Overall, in a qualitative analysis liver and striatum stand-out, 
showing a wide-range distribution of alleles, typically seen in samples with high 
instability levels while the other tissues show a much more concentrated distribution. 
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Figure 24 – Representative electropherogram traces of CAG repeat sizing in neuronal 
and non-neuronal tissues of HttQ175neo- and HttQ175neo+ mice. In the x-axes CAG repeat size is 
represented, with peaks differing by one CAG unit. Signal height is represented in the y-axes. 
Liver and striatum traces present a 2× zoom-in in signal height when compared to all other 
tissues.  
 
Quantitative analyses of instability were performed to determine expansion and 
contraction indexes as well as absolute instability (detailed information in Methods and 
Supplementary material). 
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First, we evaluated specific differences between tissues, separated in two 
groups: neuronal (cerebellum, cortex and striatum); and non-neuronal (heart, spleen, 
tail and liver) within both HttQ175neo- and HttQ175neo+ lines.  
Expansion indexes and absolute instability show a fairly straightforward picture 
(Figure 25, Figure 27), where among non-neuronal tissues, liver always shows 
significantly higher expansion indexes and absolute instability when compared to 
heart, spleen or tail, which, in this order, seem to show either trending or statistically 
significant increasing instability in both lines. Among neuronal tissues, results for 
expansions and instability are also clear, with striatum showing significantly more 
instability than cerebellum and cortex, while they appear to only differ from each other 
in HttQ175neo- mice.  
Regarding contractions (Figure 26), HttQ175neo- shows fewer differences 
between tissues than in the other indexes, with only striatum and liver showing 
significant changes relative to other neuronal and non-neuronal tissues respectively. 
In HttQ175neo+ only heart and liver differ significantly in their contraction index. 
 
Figure 25 – Expansion indexes in (A, B) non-neuronal and (C, D) neuronal tissues in 
HttQ175neo- and HttQ175neo+ mice. (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, multiplicity 
adjusted) 
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Figure 26 – Contraction indexes in (A, B) non-neuronal and (C, D) neuronal tissues in 
HttQ175neo- and HttQ175neo+ mice. (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, multiplicity 
adjusted) 
 
Figure 27 – Absolute instability in (A, B) non-neuronal and (C, D) neuronal tissues in 
HttQ175neo- and HttQ175neo+ mice. (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, multiplicity 
adjusted) 
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We then evaluated if there were any differences in expansions, contractions or 
absolute instability between the two lines, in all tissues, in order to assess specific 
alterations stemming from the presence/absence of the neo cassette. 
As stated previously, instability is influenced by CAG repeat size, and therefore 
differences in repeat length between these series of Q175 mice might influence the 
comparison (at hand). Therefore we evaluated if there were differences in the CAG 
size of the main alleles between the groups in their most stable tissues, heart and 
cerebellum (Figure 28).  
 
Figure 28 – Comparison of main allele CAG repeat sizes in cerebellum and heart for eight 
mice in the HttQ175neo- and HttQ175neo+ lines. (*p<0.05) 
 
Indeed, the two groups showed significant differences in both heart and 
cerebellum (difference between means of ~5 CAG units, heart: p=0.0368, cerebellum: 
p=0.0365). To balance CAG sizes between the lines, the two mice possessing the 
highest allele sizes in HttQ175neo- (Supplementary tables, mice E and H), as well as the 
two mice showing the shortest sizes in HttQ175neo+ (Supplementary tables, mice I and 
J) were excluded to avoid biases driven by CAG repeat differences.  
When the groups, now containing six mice, were compared regarding average 
repeat size in heart and cerebellum, they showed non-statistically significant 
differences (≤2 CAG units, heart: p=0.271, cerebellum: p=0.236, Figure 29), therefore 
these CAG size-controlled groups were considered for the downstream analysis. 
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Figure 29 – Comparison of main allele CAG repeat sizes in cerebellum and heart for six 
mice in the HttQ175neo- and HttQ175neo+ lines. 
  
When comparing either expansion, contraction indexes or absolute instability 
between the lines in the seven tissues of interest – heart, spleen, tail, liver, cerebellum, 
cortex and striatum – most comparisons showed non-significant differences 
(Supplementary figures). Even though not significant, all expansion indices 
consistently showed lower values in the HttQ175neo+ line for all tissues when compared 
to their neo- counterparts.  
Nonetheless, the liver’s absolute instability showed the only significant 
difference between the two lines (p=0.0321, Figure 30). 
 
Figure 30 – Liver absolute instability in HttQ175neo- and HttQ175neo+. (*p<0.05) 
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Keeping in mind that the delineation of the main allele influences the 
calculations of instability indexes, and that liver and striatum are the most unstable 
tissues where it is sometimes difficult to definitely assign the main allele (as seen in 
Figure 24), a different approach was taken to avoid mis-estimation of differences 
between the lines stemming from this fact. Expansion/contraction indexes and 
absolute instability were then re-calculated for liver and striatum, where the main allele 
considered for each mouse, was the highest represented in the most stable tissue of 
the same category, namely, cerebellum for striatum and heart for liver. 
 
Figure 31 – Absolute instability, expansion and contraction indexes, with correction for 
main CAG allele size in liver and striatum of HttQ175neo- and HttQ175neo+. (*p<0.05) 
 
These changes showed to a small extent a different picture regarding 
differences between the HttQ175neo- and HttQ175neo+ lines, with liver now showing 
significant differences regarding the expansion index (p=0.0178), and a still (but 
slightly more) significant difference in absolute instability (p=0.0289, Figure 31). 
Striatum still did not show any significant differences (Figure 31). 
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4.5. Discussion 
In this work we, for the first time, thoroughly describe how tissues from HttQ175 
mice differ in CAG repeat instability and determine whether the presence of a neo 
sequence upstream of the repeat modulates somatic CAG repeat instability. 
Regarding differences among tissues, Q175 (both neo- and neo+) show the 
most instability in striatum (which is also observed in post-mortem brains of patients) 
and liver, in agreement with instability levels observed in other models such as HttQ111 
and R6 mice[81,97,102,132]. All of the other tissues evaluated were far more stable, 
but surprisingly, tail which is often considered a staple among stable tissues in other 
models, did not appear the most stable even among non-neuronal tissues, consistently 
showing significantly higher expansion indexes and absolute instability specially when 
compared to heart. Among neuronal tissues, as expected, cerebellum was the most 
stable and cortex showed intermediate levels of instability. Expansion indexes 
appeared to be more dissimilar between tissues (and therefore driving differences 
between absolute instabilities) than contraction indexes, and while both lines showed 
this, differences were more prevalent and displayed more statistical significance in the 
neo- line. 
Concerning the effect of the neo insert upstream of the repeat (in instability), in 
the work described in the previous chapter we have shown a “protective” effect of the 
neo sequence in intergenerational instability, where it seemed to play a role in 
reducing the frequency of expansions in parent-to-offspring transmissions.  We 
therefore decided to evaluate if it might have a similar effect on somatic instability.  
In the series of seven tissues evaluated, most showed no significant differences 
in either expansion index, contraction index or absolute instability between the neo+ 
and neo+ mice. Nonetheless, focusing on expansion indexes, we always see lower 
indices in the HttQ175neo+ line when compared with HttQ175neo- consistent with a potential, 
although tenuous, overall protective effect on expansions. 
Liver showed the only significant differences between lines; in a first analysis 
only the absolute instability was different between the strains, and after correcting for 
main allele size both expansion index and absolute instability showed significant 
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differences. This correction for the main allele size seems a fairly sensible alteration 
to make, especially in the more unstable tissues, as their peak spread is large making 
it easy to confound the “ancestral” main allele with an allele size that became more 
prevalent exactly due to a high overall instability. 
In conclusion, here we show that cis-factors, namely this neo sequence 
upstream of the repeat, can indeed modulate somatic instability, through the reduction 
of expansion indexes which ultimately affect instability levels. 
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4.6. Supplementary material 
4.6.1. Supplementary tables 
Table S8 – Instability measures for heart 
Mouse line Mouse ID 
heart 
Average 
main allele 
Expansion 
index 
Contraction 
index 
Absolute 
instability 
HttQ175neo- 
A 201 1.905 -2.184 4.089 
B 196 1.704 -1.981 3.685 
C 195 2.104 -2.061 4.164 
D 198 1.511 -1.988 3.499 
E 203 1.690 -2.147 3.837 
F 200 2.016 -2.121 4.137 
G 196 1.869 -2.236 4.106 
H 201 1.975 -2.052 4.027 
HttQ175neo+ 
I 182 2.037 -2.027 4.064 
J 192 1.564 -2.161 3.725 
K 195 2.022 -2.013 4.035 
L 193 1.573 -2.117 3.690 
M 197 1.710 -2.017 3.727 
N 200 1.699 -1.920 3.619 
O 194 1.756 -2.221 3.977 
P 197 2.119 -2.043 4.162 
 
Table S9 – Instability measures for spleen 
Mouse line Mouse ID 
spleen 
Average 
main allele 
Expansion 
index 
Contraction 
index 
Absolute 
instability 
HttQ175neo- 
A 202 2.238 -2.714 4.952 
B 198 2.375 -2.312 4.687 
C 197 2.297 -2.527 4.824 
D 199 2.084 -2.474 4.558 
E 203 2.146 -2.411 4.557 
F 201 2.426 -2.517 4.943 
G 198 2.539 -2.366 4.905 
H 203 2.133 -2.587 4.719 
HttQ175neo+ 
I 182 2.297 -2.190 4.487 
J 192 2.009 -2.409 4.417 
K 197 2.562 -2.710 5.272 
L 194 1.940 -2.051 3.991 
M 197 2.093 -2.255 4.348 
N 201 1.944 -2.151 4.095 
O 195 1.909 -2.171 4.080 
P 199 2.315 -2.150 4.466 
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Table S10 – Instability measures for tail 
Mouse line Mouse ID 
Tail 
Average 
main allele 
Expansion 
index 
Contraction 
index 
Absolute 
instability 
HttQ175neo- 
A 202 2.948 -2.437 5.384 
B 197 2.716 -2.868 5.584 
C 197 3.175 -2.495 5.671 
D 201 2.63 -2.32 4.949 
E 203 2.531 -2.422 4.952 
F 201 2.663 -2.039 4.703 
G 198 3.043 -2.3 5.343 
H 204 2.547 -2.308 4.856 
HttQ175neo+ 
I 183 2.412 -1.832 4.244 
J 192 2.632 -2.31 4.943 
K 195 3.514 -2.302 5.817 
L 199 2.052 -2.063 4.115 
M 202 2.931 -1.829 4.76 
N 196 3.006 -2.37 5.375 
O 194 2.546 -1.95 4.496 
P 199 2.031 -2.477 4.509 
 
Table S11 – Instability measures for liver 
Mouse line Mouse ID 
liver 
Average 
main allele 
Expansion 
index 
Contraction 
index 
Absolute 
instability 
HttQ175neo- 
A 205 3.489 -4.677 8.166 
B 198 4.152 -2.977 7.129 
C 201 3.683 -4.651 8.334 
D 201 3.241 -2.702 5.943 
E 202 5.651 -2.765 8.416 
F 200 4.695 -2.805 7.500 
G 197 4.875 -2.529 7.404 
H 203 3.645 -2.853 6.498 
HttQ175neo+ 
I 182 3.139 -2.999 6.138 
J 193 2.942 -2.612 5.554 
K 196 3.626 -2.304 5.930 
L 193 3.228 -2.070 5.297 
M 197 3.832 -2.198 6.031 
N 201 5.453 -2.409 7.862 
O 194 3.583 -1.963 5.546 
P 199 2.704 -3.514 6.218 
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Table S12 – Instability measures for cerebellum 
Mouse line Mouse ID 
cerebellum 
Average 
main allele 
Expansion 
index 
Contraction 
index 
Absolute 
instability 
HttQ175neo- 
A 203 1.400 -1.914 3.314 
B 198 1.510 -1.859 3.369 
C 197 1.857 -2.228 4.085 
D 201 1.870 -2.226 4.096 
E 203 1.523 -2.076 3.599 
F 202 2.095 -2.178 4.273 
G 198 2.038 -2.095 4.133 
H 204 1.602 -2.083 3.685 
HttQ175neo+ 
I 182 2.135 -2.031 4.166 
J 193 1.431 -1.877 3.308 
K 198 1.592 -1.978 3.571 
L 195 1.514 -2.134 3.648 
M 198 1.871 -2.139 4.009 
N 202 1.416 -2.002 3.418 
O 194 1.874 -2.082 3.957 
P 200 1.993 -4.939 6.932 
 
Table S13 – Instability measures for cortex 
Mouse line Mouse ID 
cortex 
Average 
main allele 
Expansion 
index 
Contraction 
index 
Absolute 
instability 
HttQ175neo- 
A 200 2.919 -2.199 5.118 
B 196 2.490 -2.126 4.616 
C 196 2.980 -2.364 5.344 
D 199 1.721 -1.802 3.523 
E 201 2.612 -2.176 4.788 
F 200 2.591 -2.334 4.925 
G 197 2.494 -2.069 4.563 
H 201 2.800 -2.361 5.161 
HttQ175neo+ 
I 182 2.559 -2.165 4.724 
J 191 1.817 -2.082 3.899 
K 195 2.805 -2.186 4.990 
L 193 2.052 -2.435 4.488 
M 198 1.939 -2.211 4.150 
N 200 2.834 -2.082 4.916 
O 195 2.538 -2.180 4.718 
P 198 1.942 -2.800 4.743 
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Table S14 – Instability measures for striatum 
Mouse line Mouse ID 
striatum 
Average 
main allele 
Expansion 
index 
Contraction 
index 
Absolute 
instability 
HttQ175neo- 
A 204 4.469 -3.090 7.559 
B 198 6.113 -2.559 8.672 
C 198 5.240 -2.316 7.556 
D 202 4.127 -3.008 7.134 
E 203 4.031 -1.977 6.008 
F 203 4.707 -2.708 7.415 
G 200 4.924 -3.045 7.969 
H 205 4.264 -2.860 7.124 
HttQ175neo+ 
I 183 4.109 -2.751 6.861 
J 193 5.685 -2.508 8.192 
K 198 5.148 -2.668 7.817 
L 195 4.285 -2.742 7.027 
M 199 5.142 -2.381 7.523 
N 202 5.286 -2.790 8.076 
O 195 5.760 -1.886 7.645 
P 198 2.955 -2.189 5.144 
 
4.6.2. Supplemental figures 
 
Figure S17 – Comparison of instability measures in heart 
 
 
Figure S18 – Comparison of instability measures in spleen 
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Figure S19 – Comparison of instability measures in liver 
 
Figure S20 – Comparison of instability measures in cerebellum 
 
Figure S21 – Comparison of instability measures in Cortex 
 
 
Figure S22 – Comparison of instability measures in striatum 
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5. General discussion and concluding remarks
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HD is an autosomal dominant progressive neurodegenerative disorder caused 
by a CAG trinucleotide repeat expansion in exon 1 of the HTT gene located in 
4p16.3[19]. The size of the repeat is of extreme importance as it determines the 
penetrance of the disorder, and is a main driver of age-at-onset[14,19,24,33,35,51,52]. 
In a typical presentation of HD one of the features where repeat size seems to have 
less of an impact is in disease duration, which appears to be mostly constant[52], 
nonetheless, since higher CAG sizes result in earlier onset, longer CAGs will on 
average result in lower life expectancy. 
Changes in the number of CAGs, also referred to as repeat instability, either 
from one generation to another – intergenerational instability – or within somatic 
cells/tissues of an individual – somatic instability – has been identified in both patients 
and mouse models of the disorder[19,69,78–81]. Knowing the impact repeat size has 
on aspects of the disease, understanding the factors that may modulate it, either to 
prevent increases in size – expansions – in order to avoid increased penetrance and 
earlier onset, or induce changes toward small sizes –  contractions – toward delaying 
the disorder is critical.   
There also seems to exist a role for instability itself as a component of onset 
variation, as individuals with similar inherited repeat sizes but different degrees of 
instability differ greatly in age-at-onset, with larger somatically expanded repeats being 
associated with an earlier onset of disease[72]. Furthermore, an extensive GWAS 
recently showed genomic regions responsible for modulation of age-at-onset where 
DNA repair was one of the most represented pathways[54]. Members of the mismatch 
DNA repair pathway have been identified as modifiers of instability in mouse models 
of HD[90,102–104], conceivably validating the overall importance of CAG repeat 
instability in the disorder. 
With this in mind, all the projects presented in this thesis were performed toward 
a better understanding of CAG repeat instability in HD, both somatic and 
intergenerational, which included human-derived cell models, patient germline 
samples and mouse models. This overall discussion therefore aims to connect the 
findings in the projects previously presented and how they might contribute to the state 
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of the art regarding instability in HD, and ultimately contribute to help patients or 
individuals at-risk for the disorder. 
Four cell lines from individuals of a nuclear family presenting an unusual level 
of intergenerational instability, with three offspring presenting large repeat size 
changes when compared to the affected father were studied with two goals: to assess 
if the father showed somatic instability with the same propensity for repeat size 
change; and to characterize the behavior and test the adequacy of using LCLs as easy 
to handle, human-derived models for high-throughput studies of instability modulators. 
Both of these goals were achieved to the extent possible. 
The father prone to intergenerationally unstable transmissions did not show a 
particularly high instability in LCLs, possibly indicating that mechanisms of somatic 
and intergenerational instability might not be shared. However, a more systematic 
approach with a larger sample number seems to dispel this notion and indicate that 
absolute instability levels between LCL and sperm cells have a mild association, and 
expansion indexes show a particularly high correlation. The identification of this 
relationship using human samples could be especially informative for individuals with 
repeats in the intermediate and reduced penetrance ranges, as there is general 
uncertainty regarding the probability of the repeat changing toward the fully penetrant 
sizes. Somatic evaluation of the expansion index might serve as an indicator of 
propensity toward germline changes in repeat size.  
While the association described above should still be validated in a higher 
number of subjects, there are previous observations in HD mouse models, namely, 
among the most somatically unstable lines of R6 models, that also seemed to show 
the highest intergenerational changes[81]. Further, in studies searching for instability 
modifiers, most of the identified genes seem to affect both types of 
instability[90,92,102,103], showing that genetic background effects might be acting in 
both somatic cells and germline, strengthening our observations.  
Considering the observed relationship between somatic and intergenerational 
instability, there is the need to explain the exception to this trend in the previously 
mentioned father, with low somatic instability but high intergenerational instability. A 
possible reason for the exceptional level of intergenerational CAG repeat changes 
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coming from this subject is a high level of mosaicism between different tissues, where 
spermatogonia, and therefore the entire germline, might possess a substantially higher 
repeat size number then the lymphocyte-derived cells lines studied, which would 
explain this trend toward large changes. 
A relationship between CAG repeat size and instability was a common feature 
throughout the projects performed.  
It was observed in the LCLs from the family mentioned above, during the effort 
to characterize their instability behavior that the individuals with lower CAG sizes 
showed very limited changes in main allele sizes and only the offspring with longer 
repeats seemed to show appreciable levels of instability, although with a very complex 
pattern to evaluate. These facts mainly lead to the exclusion of the possibility of LCLs 
broadly being used as high throughput models for instability, as the “best case 
scenario”, which would be observing instability at the lower end of pathogenic repeat 
sizes (40-50 CAGs), and therefore more informative and most directly applicable to a 
typical affected individual, did not come to fruition. Furthermore, the complicated 
behavior of the cell lines that do show instability, with multiple populations that vary 
due to non-controllable effects, show large jumps in repeat size without an explainable 
cause, and a lack of overall consistency would not make them suitable models. These 
unstable lines do show one common observable characteristic; a cohesive 
progression of main allele size with passages within specific populations, meaning that 
if one were to successfully isolate a single LCL population with complete certainty of 
homogeneity, strongly control for any systematic changes, and try to diminish the 
effect and/or account for random variation. This approach might be feasible but 
extremely technically challenging and still enormously hard to validate. For less, or at 
most, the same amount of effort one could effectively pursue other avenues including 
studying instability in patient neuronal cell cultures which may be derived from patient 
iPSCs which are already available[133], and would be a probably more adequate and 
important model for the disorder and potentially instability. 
Dependence of instability on CAG was also observed when in the set of LCLs 
spanning a broad range of sizes (17-82 CAGs), with absolute instability, expansion 
and contraction indexes all showing a high correlation with repeat size. 
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CAG repeat length also showed a very prominent effect on intergenerational 
instability in knock-in mouse models of HD, where it affected the frequency of 
expansions as well as the magnitude of both expansions and contractions, especially 
when considering lines with underlying larger repeats (HttQ111 and longer).  
Therefore great care was undertaken to appropriately evaluate instability, 
always controlling for this prominent role of CAG size. In the LCL samples spanning 
the broad repeat range, CAG-independent instability was evaluated through the 
calculation of residual absolute instability, residual expansion and residual contraction 
values, highlighting the difference between observed values and the expected 
instability in case CAG was the only contributing component. In the study of 
intergenerational changes in mouse models, performing the comparison between 
distinct strains while adjusting for different average and range of repeat sizes was 
more technically challenging, and a methodology – that included theoretical modelling 
of expected frequency distributions contingent to a reference strain – had to be 
developed in order for a fair amount of confidence to be present in this analysis. In 
other cases such as the evaluation of the neo insert in both intergenerational and 
somatic instability, ultimately the ranges had to be adapted and some samples ended 
up being excluded, resulting in the evaluation of a lower number of observations and 
a consequential loss of statistical power to detect differences, but a greater confidence 
that the effects found were real and were not by CAG repeat size effects.  
A significant effort was performed to try to pinpoint specific genes that 
correlated with the different measures of instability. Regarding somatic changes, this 
was evaluated by testing the correlations between CAG-independent instability and 
the expression levels of genes involved in DNA replication and repair, which, based 
on previous studies, are the pathways most likely to harbor instability modifier genes. 
Only two genes, NTHL1 and POLD1, presented a significant correlation after multiple 
testing correction, providing candidates that modulate contractions. If we also consider 
nominally significant correlations we do see additional interesting genes notably, TP73 
expression correlates with absolute instability and expansions, and FAN1 and LIG1 
correlating with contractions.  
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Concerning intergenerational instability, we identified differences between 
frequency and magnitude of expansions, contractions or unchanged transmissions 
among different mouse strains. To accurately pinpoint which specific genetic variants 
would be responsible for these differences, a thorough linkage mapping effort should 
be undertaken as has been done for somatic instability in the B6 and 129 strains[102]. 
However, we also found differences in instability between B6J and B6N strains, the 
most genetically similar among the background strains compared. It may therefore be 
easier to pinpoint a genetic causal differences as their overall number is more limited 
than when equating any other line. As stated previously no coding or regulatory SNPs 
in MMR genes or genes in other DNA repair pathways that might explain the 
differences between B6 and B6J strains. However, if the analysis is expanded even 
further, by the inclusion of not only SNPs but also indel variants, or by evaluating 
genome-wide differences in the Mouse Phenome Database (http://phenome.jax.org/), 
two interesting candidates are found: 1) an insertion/deletion of one base in the coding 
region of Lig1 resulting in a frameshift mutation; and 2) a SNP in B6N causing a stop 
codon gain (therefore a non-sense mutation) in Spata31, a spermatogenesis 
associated gene, which is of particular notice since our evaluation of differences 
between strains was based on paternal transmissions. 
So, overall we can use the information here gathered to evaluate the viability of 
using these genes as targets for the reduction of expansions or induction of 
contractions, the most eventual useful scenarios for patients and people at-risk for HD. 
NTHL1 encodes endonuclease III-like protein 1, a protein that participates in 
base excision repair of oxidative lesions. We see that low levels of NTHL1 expression 
are correlated with contractions. Following this path might be problematic, as 
diminishing the expression levels should be done with enough precision not to abolish 
expression and function, as loss-of-function mutations in NTHL1 are responsible for 
different types of tumors[134,135]. Knockout models for the mouse ortholog Nth1 also 
show other consequences such as increased telomere fragility[136]. Additionally, 
other studies in mice show that the lack of Nth1 might reduce protection from oxidative 
DNA damage, when other DNA repair machinery involved in BER (namely, 
Neil1)[137], or even MMR (Msh2)[138] are also lacking. Lack of Nth1 also diminishes 
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protection from replication oxidative stress in a telomerase null background[136]. 
Therefore, even if done conservatively, modulating the expression of this gene might 
result in unplanned and unexpected consequences that might outweigh benefits. 
POLD1 codes for the p125 subunit of polymerase δ (Polδ), which is known to 
be involved in both DNA replication and repair. The contraction modulation scenario 
is very similar to the described above; low expression levels of POLD1 also correlate 
with contraction magnitude, but the disadvantages of wrongfully modulating the 
expression of this gene might be as severe or worse than NTHL1. Polδ is essential for 
DNA replication, and is extremely important for many of the DNA repair pathways, 
including MMR[139,140]. Downregulation of POLD1 has been shown to arrest cell 
cycle and DNA synthesis and suppress cell proliferation[141], POLD1 depletion 
causes genomic instability, observed as DNA breaks and chromosome abnormalities, 
and total loss of function from the catalytic domain has been associated with different 
types of cancer[142] and also a multisystem disorder[143]. Consequently, the pros 
and cons of modulating its expression should be strongly evaluated. 
TP73 is responsible for the production of the p73 protein, from the p53 family. 
While it would have been problematic to reduce TP73 expression, as knock-out mice 
have shown a phenotype of neurodegeneration[144], in the case of this gene an 
increase in expression levels seems to protect against expansions and absolute 
instability. TP73 appears to have multiple main functions and important roles, among 
them, neuronal stem cell maintenance[145], and an anti-apoptotic role during neuronal 
development[146], both of which probably important in HD. Nevertheless, the inherent 
biology of TP73 and p73 appears to be very complex, with multiple promoters and 
alternative splicing in play[145], where different isoforms seem to have distinct roles, 
namely in tumor suppression or tumor progression, depending on the isoform 
considered[147,148]. Thus, before trying to modulate repeat instability with TP73, a 
more detailed investigation would have to be performed, in order to understand if a 
specific isoform might be driving this expansion protection effect, and if so, confirm 
that this induced overexpression would not tilt the functional balance toward the 
oncogenic side. 
  
123 
 
FAN1 encodes FANCI-associated nuclease 1, whose main functions relate to 
DNA interstrand crosslink repair and processing of stalled replication forks[149,150]. 
Larger contractions seem to correlate with higher expression levels of FAN1, and while 
there is phenotypic characterization of the effects of Fan1 knock-out in mice[151] and 
nuclease-defective knockins[149], possible harmful  effects of overexpression are not 
clear. Nonetheless, it is important to note that FAN1 is located in the most significant 
locus associated with residual age-at-onset in the recent GWAS[54] and assuming 
that instability might be the intermediate in this modulation, it is interesting to 
hypothesize that a naturally occurring variant might be responsible for increased 
expression and therefore an increase in contractions, altering age-at-onset.  
LIG1 is also an interesting candidate, as several pieces of evidence indicate it 
may be a useful modifier. From the work here presented, lower levels of LIG1 
expression seem to correlate with contraction magnitude in LCLs. There is a significant 
difference between the B6J and B6N strains in terms of expansion and contraction 
frequency and magnitude in intergenerational transmissions, which can be due to a 
coding functional indel in the mouse ortholog Lig1. Furthermore, the literature indicates 
that Lig1 expression levels are higher in cerebellum where the CAG repeat shows 
higher stability when compared to striatum which shows high instability[106]. 
Additionally, a study using a mouse model of DM1, a CTG repeat expansion-caused 
neuromuscular disorder that presents instability, identified, a defective Lig1 (with ~3% 
of normal activity) that appeared to reduce the frequency of expansions and increase 
the frequency of contractions in female repeat transmissions (although we should keep 
in mind that no changes were observed in male transmissions or somatic changes, 
creating a more complex scenario)[110]. LIG1 encodes ligase I, a protein involved in 
both DNA replication and repair. Interestingly, unlike the some of the genes mentioned 
above, knock-out mice for Lig1 does not seem to present DNA repair impairment, 
possibly because of redundant functionality from other ligases. Rather, phenotypes of 
these mice seem to be related to problems in DNA replication and not repair[152]. With 
these observations in mind, there is a large opportunity to further explore the potential 
of LIG1 as a modulator of instability, specifically in non-replicating cells such as 
neurons, as there are many factors indicating it might be beneficial without any 
predictable disadvantages. Specifically, it might be interesting to evaluate somatic 
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expansion and contraction indexes, in replicating and non-replicating tissues, as well 
as intergenerational changes in HD mouse models expressing the low activity Lig1 as 
mentioned in the DM1 study[110] to confirm the observations here stated.  
Finally, Spata31 should also be considered, but especially regarding a role in 
intergenerational instability among paternal transmissions, as the protein it produces, 
spermatogenesis-associated protein 31, appears not to be present in any tissue 
besides the male germline in mice. It is very hard to pinpoint how this factor might be 
influencing instability as the protein function is not clear. Our in silico analyses did not 
reveal any clear functional domain and studies in mice have only related it to 
fertility[153]. In humans, there is a large family of SPATA31 genes with high homology 
between them, containing multiple isoforms which might have even acquired new 
functions, since the evolutionary deviation from mice[154], potentially complicating the 
translation of discoveries made in the mouse to applicability in  patients.  
Regarding intergenerational instability, a great effort was performed to 
thoroughly evaluate the largest breeding datasets available to date from HD knock-in 
mouse models. Beside the findings already mentioned in this discussion – the CAG 
dependence regarding frequency and magnitude of changes, and the genetic 
background effects evaluated between strains – due to the overlap with conclusions 
from other projects, there are other important observations also worth mentioning.  
To begin with, we observed that the presence of an expanded CAG allele did 
not seem to skew the overall proportion of heterozygous and wild-type offspring 
independently of CAG size, showing different results from what has been observed in 
other diseases[118–121], but in accordance with previous results from single sperm 
genotype of HD-affected individuals, suggesting that the repeat size does not seem to 
be the inherent cause of the distortions observed. 
Sex-of-parent effects, that were already thoroughly studied 
previously[60,63,64,78] were confirmed, namely the significant differences in the 
frequency of expansions, much higher in paternal transmissions, and frequency of 
contractions, that were predominant in maternal transmissions. These differences 
probably stem from intrinsic differences in gamete formation processes. Interestingly, 
magnitude of changes was not different between paternal and maternal transmissions, 
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indicating that the differences in gametogenesis have a stronger role in determining 
the occurrence of the event, but does not overly influence the extent of the repeat 
change. 
Sex-of-offspring effects were previously described both in humans and 
transgenic mouse models of the disorder[60,89], but we observed no such effects in 
any of the knock-in lines evaluated, regarding either frequency or magnitude of 
changes in paternal or maternal transmissions, suggesting that in knock-in mouse 
models, effects other than post-zygotic X or Y-encoded factors influence instability. 
One more interesting result was the observation that cis-effectors, in this case 
in the form of a neomycin resistance cassette upstream of the repeat, alter the 
frequency of changes in intergenerational transmissions, by reducing the relative 
frequency of expansions, with a slight increase in both contraction and stable 
transmissions. The presence of cis-effects have been previously suggested in 
transgenic mouse models[81], but have not been described in HD knock-in models.  
To complement this observation we also evaluated the impact of the upstream 
neo in seven tissues of HttQ175 models, and only observed significant effects in liver, 
the most unstable among the peripheral tissues, in the same direction as 
intergenerational instability, where HttQ175neo+ mice show a protective effect regarding 
expansions. 
A possible explanation might involve changes in DNA conformation stemming 
from the presence of the neo sequence through a short-range interaction with the CAG 
repeat sequence. 
The contents present in this thesis do contribute to the state of the art in the 
field of CAG repeat instability in Huntington’s disease. It shows that patient-derived 
cell lines, in this case LCLs, are an important and fruitful resource to use when 
evaluating instability, and even though they are on the easier to culture and maintain 
side of cell lines they might not be the most suited model to use for screenings (e.g. 
small molecule/drug screenings) as they show inherent complexity of CAG repeat size 
changes. It also focuses on the importance of checking and controlling for CAG size 
effects on instability in order to accurately describe different factors influencing 
  
126 
 
changes. It proposes that germ line and somatic instability might share some common 
ground. It suggests genes to be studied more in depth as instability modifiers based 
on data gathered from patient derived cells. It includes a very substantial effort to 
thoroughly evaluate the contributors to intergenerational instability in knock-in mouse 
models of HD, confirming some previous observations and shedding light into new 
ones using the largest breeding datasets available to date, after careful curation and 
validation to ensure the highest possible data quality and results. Finally, it also 
transposes one of these new observations into somatic instability in an HD model. 
Overall the results here presented open some new hypothesis and point towards 
possible directions in future studies of HTT CAG repeat instability. 
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